JP2013537203A - 三環式化合物、製造方法、およびそれらの使用 - Google Patents

Info

Publication number

JP2013537203A

JP2013537203A JP2013528497A JP2013528497A JP2013537203A JP 2013537203 A JP2013537203 A JP 2013537203A JP 2013528497 A JP2013528497 A JP 2013528497A JP 2013528497 A JP2013528497 A JP 2013528497A JP 2013537203 A JP2013537203 A JP 2013537203A

Authority

JP

Japan

Prior art keywords

trifluoromethyl

oxy

chloro

phenyl

dihydro

Prior art date

2010-09-20

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 150000001875 compounds Chemical class 0.000 title claims abstract description 454
• 238000004519 manufacturing process Methods 0.000 title claims description 11
• 238000000034 method Methods 0.000 claims abstract description 353
• 201000001320 Atherosclerosis Diseases 0.000 claims abstract description 9
• 206010012688 Diabetic retinal oedema Diseases 0.000 claims abstract description 3
• 201000011190 diabetic macular edema Diseases 0.000 claims abstract description 3
• 150000003839 salts Chemical class 0.000 claims description 46
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 40
• 125000001424 substituent group Chemical group 0.000 claims description 31
• 125000001072 heteroaryl group Chemical group 0.000 claims description 24
• 208000015122 neurodegenerative disease Diseases 0.000 claims description 23
• 230000004770 neurodegeneration Effects 0.000 claims description 22
• 239000008194 pharmaceutical composition Substances 0.000 claims description 22
• 208000024827 Alzheimer disease Diseases 0.000 claims description 21
• 201000004810 Vascular dementia Diseases 0.000 claims description 15
• 239000003814 drug Substances 0.000 claims description 12
• 229910052799 carbon Inorganic materials 0.000 claims description 11
• 206010012601 diabetes mellitus Diseases 0.000 claims description 8
• 229910052731 fluorine Inorganic materials 0.000 claims description 6
• 229910052757 nitrogen Inorganic materials 0.000 claims description 6
• 208000010837 Diabetic eye disease Diseases 0.000 claims description 5
• 208000030533 eye disease Diseases 0.000 claims description 5
• 229910052739 hydrogen Inorganic materials 0.000 claims description 5
• 229910052760 oxygen Inorganic materials 0.000 claims description 5
• 125000004076 pyridyl group Chemical group 0.000 claims description 5
• 229910052801 chlorine Inorganic materials 0.000 claims description 4
• 229910052717 sulfur Inorganic materials 0.000 claims description 4
• 125000000714 pyrimidinyl group Chemical group 0.000 claims description 3
• 239000003937 drug carrier Substances 0.000 claims description 2
• 125000001475 halogen functional group Chemical group 0.000 claims 7
• 239000000203 mixture Substances 0.000 abstract description 62
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 35
• 201000010099 disease Diseases 0.000 abstract description 31
• 230000000694 effects Effects 0.000 abstract description 22
• 230000008569 process Effects 0.000 abstract description 8
• 108010024976 Asparaginase Proteins 0.000 abstract description 4
• 238000002360 preparation method Methods 0.000 abstract description 4
• 102000016752 1-Alkyl-2-acetylglycerophosphocholine Esterase Human genes 0.000 abstract 2
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 260
• 230000014759 maintenance of location Effects 0.000 description 254
• XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 194
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 151
• 239000000243 solution Substances 0.000 description 125
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 94
• 238000000746 purification Methods 0.000 description 84
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 78
• 239000000047 product Substances 0.000 description 75
• GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 73
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 68
• JFDZBHWFFUWGJE-UHFFFAOYSA-N benzenecarbonitrile Natural products N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 67
• 235000019439 ethyl acetate Nutrition 0.000 description 66
• 239000011541 reaction mixture Substances 0.000 description 65
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 62
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 57
• -1 ester fatty acid Chemical class 0.000 description 55
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 54
• 239000011734 sodium Substances 0.000 description 38
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 36
• 239000002904 solvent Substances 0.000 description 36
• 239000007787 solid Substances 0.000 description 35
• PVKCAQKXTLCSBC-UHFFFAOYSA-N 1h-isoquinolin-4-one Chemical compound C1=CC=C2C(=O)C=NCC2=C1 PVKCAQKXTLCSBC-UHFFFAOYSA-N 0.000 description 33
• 238000005481 NMR spectroscopy Methods 0.000 description 33
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 32
• 239000003208 petroleum Substances 0.000 description 31
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 27
• CIVQDIGHVMGTPD-UHFFFAOYSA-N pyrimido[6,1-a]isoquinolin-4-one Chemical compound C1=CC=C2C=CN3C(=O)N=CC=C3C2=C1 CIVQDIGHVMGTPD-UHFFFAOYSA-N 0.000 description 26
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 25
• 238000003556 assay Methods 0.000 description 24
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 23
• 238000006243 chemical reaction Methods 0.000 description 23
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 22
• 125000000217 alkyl group Chemical group 0.000 description 20
• 239000000546 pharmaceutical excipient Substances 0.000 description 20
• 239000012267 brine Substances 0.000 description 19
• 125000005843 halogen group Chemical group 0.000 description 19
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 19
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
• NXMYLLIQRKHHHH-UHFFFAOYSA-N 2-chloro-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN1C2=CC(Cl)=NC1=O NXMYLLIQRKHHHH-UHFFFAOYSA-N 0.000 description 17
• MOFRJTLODZILCR-UHFFFAOYSA-N 2-fluoro-5-formylbenzonitrile Chemical compound FC1=CC=C(C=O)C=C1C#N MOFRJTLODZILCR-UHFFFAOYSA-N 0.000 description 17
• UGEJOEBBMPOJMT-UHFFFAOYSA-N 3-(trifluoromethyl)phenol Chemical compound OC1=CC=CC(C(F)(F)F)=C1 UGEJOEBBMPOJMT-UHFFFAOYSA-N 0.000 description 17
• BXEUKQZROZEEST-UHFFFAOYSA-N 2-chloro-9-fluoro-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(F)=CC=C2C=1CCN1C2=CC(Cl)=NC1=O BXEUKQZROZEEST-UHFFFAOYSA-N 0.000 description 16
• ZLFPIEUWXNRPNM-UHFFFAOYSA-N 4-chloro-3-(trifluoromethyl)phenol Chemical compound OC1=CC=C(Cl)C(C(F)(F)F)=C1 ZLFPIEUWXNRPNM-UHFFFAOYSA-N 0.000 description 16
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 16
• 239000000460 chlorine Substances 0.000 description 16
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 16
• 239000000741 silica gel Substances 0.000 description 16
• 229910002027 silica gel Inorganic materials 0.000 description 16
• 208000029725 Metabolic bone disease Diseases 0.000 description 15
• 230000008499 blood brain barrier function Effects 0.000 description 15
• 210000001218 blood-brain barrier Anatomy 0.000 description 15
• IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 15
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 15
• 239000003358 phospholipase A2 inhibitor Substances 0.000 description 15
• FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 15
• 239000003153 chemical reaction reagent Substances 0.000 description 14
• 229910052938 sodium sulfate Inorganic materials 0.000 description 14
• 235000011152 sodium sulphate Nutrition 0.000 description 14
• 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 13
• DPEAGIAUFYCHJN-UHFFFAOYSA-N 2-chloro-9-methyl-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(C)=CC=C2C=1CCN1C2=CC(Cl)=NC1=O DPEAGIAUFYCHJN-UHFFFAOYSA-N 0.000 description 12
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
• 208000001344 Macular Edema Diseases 0.000 description 12
• 206010025415 Macular oedema Diseases 0.000 description 12
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
• 239000012043 crude product Substances 0.000 description 12
• 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 12
• 201000010230 macular retinal edema Diseases 0.000 description 12
• JPHKMYXKNKLNDF-UHFFFAOYSA-N 3,4-difluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1F JPHKMYXKNKLNDF-UHFFFAOYSA-N 0.000 description 11
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 11
• 125000004429 atom Chemical group 0.000 description 11
• 239000003921 oil Substances 0.000 description 11
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 11
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 10
• 239000003795 chemical substances by application Substances 0.000 description 10
• 238000004440 column chromatography Methods 0.000 description 10
• 239000012071 phase Substances 0.000 description 10
• HKFTWCYLLSCXHM-UHFFFAOYSA-N 2-chloro-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C12=CC=CC=C2CCN2C1=CC(Cl)=NC2=O HKFTWCYLLSCXHM-UHFFFAOYSA-N 0.000 description 9
• 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 9
• 239000002253 acid Substances 0.000 description 9
• 125000003118 aryl group Chemical group 0.000 description 9
• 239000002585 base Substances 0.000 description 9
• 239000007788 liquid Substances 0.000 description 9
• 230000002829 reductive effect Effects 0.000 description 9
• 239000000725 suspension Substances 0.000 description 9
• 125000004432 carbon atom Chemical group C* 0.000 description 8
• 239000002552 dosage form Substances 0.000 description 8
• 201000006417 multiple sclerosis Diseases 0.000 description 8
• 229910000027 potassium carbonate Inorganic materials 0.000 description 8
• RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 7
• 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 7
• KAXIYYPIORYZLB-UHFFFAOYSA-N 5-hydroxypyridine-3-carbonitrile Chemical compound OC1=CN=CC(C#N)=C1 KAXIYYPIORYZLB-UHFFFAOYSA-N 0.000 description 7
• 208000001132 Osteoporosis Diseases 0.000 description 7
• 210000004556 brain Anatomy 0.000 description 7
• 238000003818 flash chromatography Methods 0.000 description 7
• 230000006870 function Effects 0.000 description 7
• ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 description 7
• 230000002757 inflammatory effect Effects 0.000 description 7
• 229910000104 sodium hydride Inorganic materials 0.000 description 7
• KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 6
• ZGRMZJDLYWLJES-UHFFFAOYSA-N 2-[4-chloro-3-(trifluoromethyl)phenoxy]-5-formylbenzonitrile Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C(=CC(C=O)=CC=2)C#N)=C1 ZGRMZJDLYWLJES-UHFFFAOYSA-N 0.000 description 6
• UOQXIWFBQSVDPP-UHFFFAOYSA-N 4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-UHFFFAOYSA-N 0.000 description 6
• YLSOMBNWTNQJJO-UHFFFAOYSA-N 5-(hydroxymethyl)-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound N#CC1=CC(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 YLSOMBNWTNQJJO-UHFFFAOYSA-N 0.000 description 6
• FXGGBYQVSQGHNJ-UHFFFAOYSA-N 5-[4-fluoro-3-(trifluoromethyl)phenoxy]pyridine-2-carbaldehyde Chemical compound C1=C(C(F)(F)F)C(F)=CC=C1OC1=CC=C(C=O)N=C1 FXGGBYQVSQGHNJ-UHFFFAOYSA-N 0.000 description 6
• VFOBDHYPESAMAF-UHFFFAOYSA-N 6-(trifluoromethyl)pyridin-3-ol Chemical compound OC1=CC=C(C(F)(F)F)N=C1 VFOBDHYPESAMAF-UHFFFAOYSA-N 0.000 description 6
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
• 208000030136 Marchiafava-Bignami Disease Diseases 0.000 description 6
• SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 6
• 239000000543 intermediate Substances 0.000 description 6
• 208000002780 macular degeneration Diseases 0.000 description 6
• 238000004949 mass spectrometry Methods 0.000 description 6
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
• 230000000750 progressive effect Effects 0.000 description 6
• 230000002441 reversible effect Effects 0.000 description 6
• 239000011780 sodium chloride Substances 0.000 description 6
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 6
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
• FZPVTRFOICFIFA-UHFFFAOYSA-N 1-chloro-4-(4-nitrophenoxy)-2-(trifluoromethyl)benzene Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 FZPVTRFOICFIFA-UHFFFAOYSA-N 0.000 description 5
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 5
• LSCMGEBJXSDFPK-UHFFFAOYSA-N 3,5-difluoro-4-[6-(trifluoromethyl)pyridin-3-yl]oxybenzaldehyde Chemical compound FC1=CC(C=O)=CC(F)=C1OC1=CC=C(C(F)(F)F)N=C1 LSCMGEBJXSDFPK-UHFFFAOYSA-N 0.000 description 5
• UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 5
• ISFVMFIENWPRHV-UHFFFAOYSA-N 5-[3-(trifluoromethyl)phenoxy]pyridine-2-carbaldehyde Chemical compound FC(F)(F)C1=CC=CC(OC=2C=NC(C=O)=CC=2)=C1 ISFVMFIENWPRHV-UHFFFAOYSA-N 0.000 description 5
• YXUUCJCERVOZRN-UHFFFAOYSA-N 5-[4-chloro-3-(trifluoromethyl)phenoxy]pyridine-2-carbonitrile Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=NC(=CC=2)C#N)=C1 YXUUCJCERVOZRN-UHFFFAOYSA-N 0.000 description 5
• IHSJAHYEAPHXJI-UHFFFAOYSA-N 5-ethenyl-2-[5-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound N1=CC(C(F)(F)F)=CC=C1OC1=CC=C(C=C)C=C1C#N IHSJAHYEAPHXJI-UHFFFAOYSA-N 0.000 description 5
• MNOGYCPIVIXHRK-UHFFFAOYSA-N 6-chloro-5-fluoropyridine-3-carbaldehyde Chemical compound FC1=CC(C=O)=CN=C1Cl MNOGYCPIVIXHRK-UHFFFAOYSA-N 0.000 description 5
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 5
• 108010090849 Amyloid beta-Peptides Proteins 0.000 description 5
• 102000013455 Amyloid beta-Peptides Human genes 0.000 description 5
• 208000002691 Choroiditis Diseases 0.000 description 5
• 102000004127 Cytokines Human genes 0.000 description 5
• 108090000695 Cytokines Proteins 0.000 description 5
• 206010012689 Diabetic retinopathy Diseases 0.000 description 5
• 239000007995 HEPES buffer Substances 0.000 description 5
• 206010049088 Osteopenia Diseases 0.000 description 5
• 208000018737 Parkinson disease Diseases 0.000 description 5
• 208000003971 Posterior uveitis Diseases 0.000 description 5
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
• NPELSDLGIFSEAU-UHFFFAOYSA-N [3,5-difluoro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]methanol Chemical compound FC1=CC(CO)=CC(F)=C1OC1=CC=C(C(F)(F)F)N=C1 NPELSDLGIFSEAU-UHFFFAOYSA-N 0.000 description 5
• 230000005856 abnormality Effects 0.000 description 5
• 125000003545 alkoxy group Chemical group 0.000 description 5
• 229910052786 argon Inorganic materials 0.000 description 5
• 239000012131 assay buffer Substances 0.000 description 5
• 230000015572 biosynthetic process Effects 0.000 description 5
• 210000000988 bone and bone Anatomy 0.000 description 5
• 230000015556 catabolic process Effects 0.000 description 5
• 238000007796 conventional method Methods 0.000 description 5
• 238000005194 fractionation Methods 0.000 description 5
• 125000000592 heterocycloalkyl group Chemical group 0.000 description 5
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
• 239000003112 inhibitor Substances 0.000 description 5
• 230000002401 inhibitory effect Effects 0.000 description 5
• 150000002632 lipids Chemical class 0.000 description 5
• 239000012044 organic layer Substances 0.000 description 5
• 230000003647 oxidation Effects 0.000 description 5
• 238000007254 oxidation reaction Methods 0.000 description 5
• 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 5
• 239000011591 potassium Substances 0.000 description 5
• 229910052700 potassium Inorganic materials 0.000 description 5
• 125000006239 protecting group Chemical group 0.000 description 5
• 238000011160 research Methods 0.000 description 5
• 239000012312 sodium hydride Substances 0.000 description 5
• 235000009518 sodium iodide Nutrition 0.000 description 5
• 239000007858 starting material Substances 0.000 description 5
• 238000002560 therapeutic procedure Methods 0.000 description 5
• 210000001519 tissue Anatomy 0.000 description 5
• XOXPUQPUGAPTIV-UHFFFAOYSA-N 2,9-dichloro-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(Cl)=CC=C2C=1CCN1C2=CC(Cl)=NC1=O XOXPUQPUGAPTIV-UHFFFAOYSA-N 0.000 description 4
• YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 4
• IGTLGJATSMTYPI-UHFFFAOYSA-N 2-(5-chloropyridin-3-yl)oxy-5-formylbenzonitrile Chemical compound ClC1=CN=CC(OC=2C(=CC(C=O)=CC=2)C#N)=C1 IGTLGJATSMTYPI-UHFFFAOYSA-N 0.000 description 4
• NPQHLGHJOPIBPW-UHFFFAOYSA-N 2-[4-chloro-3-(trifluoromethyl)phenoxy]-5-(hydroxymethyl)benzonitrile Chemical compound N#CC1=CC(CO)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 NPQHLGHJOPIBPW-UHFFFAOYSA-N 0.000 description 4
• OCDIXLIEHDFWPU-UHFFFAOYSA-N 3-fluoro-4-(6-methylpyridin-3-yl)oxybenzaldehyde Chemical compound C1=NC(C)=CC=C1OC1=CC=C(C=O)C=C1F OCDIXLIEHDFWPU-UHFFFAOYSA-N 0.000 description 4
• OLOALEXMPHCBOU-UHFFFAOYSA-N 3-fluoro-4-[6-(trifluoromethyl)pyridin-2-yl]oxybenzaldehyde Chemical compound FC1=CC(C=O)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 OLOALEXMPHCBOU-UHFFFAOYSA-N 0.000 description 4
• OESZKPAYOWQNHK-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 OESZKPAYOWQNHK-UHFFFAOYSA-N 0.000 description 4
• ZTOLRUVWXRBHJZ-UHFFFAOYSA-N 5-(2-hydroxyethyl)-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound N#CC1=CC(CCO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 ZTOLRUVWXRBHJZ-UHFFFAOYSA-N 0.000 description 4
• WLPJMJLNJNJHFW-UHFFFAOYSA-N 5-(2-hydroxyethyl)-2-[5-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound N#CC1=CC(CCO)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 WLPJMJLNJNJHFW-UHFFFAOYSA-N 0.000 description 4
• CBDQXFDGURBXLX-UHFFFAOYSA-N 5-(2-hydroxyethyl)-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound N#CC1=CC(CCO)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 CBDQXFDGURBXLX-UHFFFAOYSA-N 0.000 description 4
• GPJBTTKJWVPPLE-UHFFFAOYSA-N 5-(chloromethyl)-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(CCl)=CC=2)C#N)=C1 GPJBTTKJWVPPLE-UHFFFAOYSA-N 0.000 description 4
• LNQYSFMHULVPMR-UHFFFAOYSA-N 5-(hydroxymethyl)-2-[6-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound N#CC1=CC(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 LNQYSFMHULVPMR-UHFFFAOYSA-N 0.000 description 4
• UXMBJIUGDGHGDJ-UHFFFAOYSA-N 5-[4-chloro-3-(trifluoromethyl)phenoxy]pyridine-2-carbaldehyde Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=NC(C=O)=CC=2)=C1 UXMBJIUGDGHGDJ-UHFFFAOYSA-N 0.000 description 4
• RZFMHGCJZHJULU-UHFFFAOYSA-N 5-formyl-2-[2-(trifluoromethyl)pyrimidin-5-yl]oxybenzonitrile Chemical compound C1=NC(C(F)(F)F)=NC=C1OC1=CC=C(C=O)C=C1C#N RZFMHGCJZHJULU-UHFFFAOYSA-N 0.000 description 4
• ZTWOVRSSVBZCBP-UHFFFAOYSA-N 5-formyl-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(C=O)=CC=2)C#N)=C1 ZTWOVRSSVBZCBP-UHFFFAOYSA-N 0.000 description 4
• WEFCWXHRKORAQH-UHFFFAOYSA-N 5-formyl-2-[6-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(C=O)=CC=2)C#N)=N1 WEFCWXHRKORAQH-UHFFFAOYSA-N 0.000 description 4
• AMIAYJANCJPAQD-UHFFFAOYSA-N 5-formyl-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound C1=NC(C(F)(F)F)=CC=C1OC1=CC=C(C=O)C=C1C#N AMIAYJANCJPAQD-UHFFFAOYSA-N 0.000 description 4
• XXRUAAOADAPPII-UHFFFAOYSA-N 6-(trifluoromethyl)-1h-pyridin-2-one Chemical compound OC1=CC=CC(C(F)(F)F)=N1 XXRUAAOADAPPII-UHFFFAOYSA-N 0.000 description 4
• DHLUJPLHLZJUBW-UHFFFAOYSA-N 6-methylpyridin-3-ol Chemical compound CC1=CC=C(O)C=N1 DHLUJPLHLZJUBW-UHFFFAOYSA-N 0.000 description 4
• FEJUGLKDZJDVFY-UHFFFAOYSA-N 9-borabicyclo[3.3.1]nonane Substances C1CCC2CCCC1B2 FEJUGLKDZJDVFY-UHFFFAOYSA-N 0.000 description 4
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
• 206010012289 Dementia Diseases 0.000 description 4
• 206010048554 Endothelial dysfunction Diseases 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• 208000010412 Glaucoma Diseases 0.000 description 4
• 206010061218 Inflammation Diseases 0.000 description 4
• 206010022489 Insulin Resistance Diseases 0.000 description 4
• 108090001030 Lipoproteins Proteins 0.000 description 4
• 102000004895 Lipoproteins Human genes 0.000 description 4
• 208000022873 Ocular disease Diseases 0.000 description 4
• 102100026918 Phospholipase A2 Human genes 0.000 description 4
• 101710096328 Phospholipase A2 Proteins 0.000 description 4
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 4
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
• 230000002378 acidificating effect Effects 0.000 description 4
• 206010064930 age-related macular degeneration Diseases 0.000 description 4
• 150000001412 amines Chemical class 0.000 description 4
• 239000012230 colorless oil Substances 0.000 description 4
• 229940125904 compound 1 Drugs 0.000 description 4
• ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical group O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 description 4
• 229940079593 drug Drugs 0.000 description 4
• 230000008694 endothelial dysfunction Effects 0.000 description 4
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
• 238000002474 experimental method Methods 0.000 description 4
• 239000000706 filtrate Substances 0.000 description 4
• 230000004054 inflammatory process Effects 0.000 description 4
• 230000005764 inhibitory process Effects 0.000 description 4
• 230000001537 neural effect Effects 0.000 description 4
• RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 4
• 150000003904 phospholipids Chemical class 0.000 description 4
• SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• LTXJLQINBYSQFU-UHFFFAOYSA-N pyrimidin-5-ol Chemical compound OC1=CN=CN=C1 LTXJLQINBYSQFU-UHFFFAOYSA-N 0.000 description 4
• 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 4
• 229920006395 saturated elastomer Polymers 0.000 description 4
• SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
• LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
• 239000000758 substrate Substances 0.000 description 4
• 238000010189 synthetic method Methods 0.000 description 4
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
• GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 3
• 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 3
• JBGGXIUZIZQNSX-UHFFFAOYSA-N 1-chloro-4-[4-(difluoromethyl)phenoxy]-2-(trifluoromethyl)benzene Chemical compound C1=CC(C(F)F)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 JBGGXIUZIZQNSX-UHFFFAOYSA-N 0.000 description 3
• WFQDTOYDVUWQMS-UHFFFAOYSA-N 1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1 WFQDTOYDVUWQMS-UHFFFAOYSA-N 0.000 description 3
• ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 3
• SFUNVKXTODHDQY-UHFFFAOYSA-N 2-(3-methoxyphenyl)ethylurea Chemical compound COC1=CC=CC(CCNC(N)=O)=C1 SFUNVKXTODHDQY-UHFFFAOYSA-N 0.000 description 3
• LBWZIPYSLCRXBA-UHFFFAOYSA-N 2-(5-chloropyridin-2-yl)oxy-5-(hydroxymethyl)benzonitrile Chemical compound N#CC1=CC(CO)=CC=C1OC1=CC=C(Cl)C=N1 LBWZIPYSLCRXBA-UHFFFAOYSA-N 0.000 description 3
• QPAXXIOBBIIATH-UHFFFAOYSA-N 2-(trifluoromethyl)pyrimidin-5-ol Chemical compound OC1=CN=C(C(F)(F)F)N=C1 QPAXXIOBBIIATH-UHFFFAOYSA-N 0.000 description 3
• SDTDOFQFJVINAU-UHFFFAOYSA-N 2-[3-fluoro-4-(6-methylpyridin-3-yl)oxyphenyl]ethanol Chemical compound C1=NC(C)=CC=C1OC1=CC=C(CCO)C=C1F SDTDOFQFJVINAU-UHFFFAOYSA-N 0.000 description 3
• WBIVBAPHPMEJJY-UHFFFAOYSA-N 2-[[2-chloro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C(=C1)Cl)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 WBIVBAPHPMEJJY-UHFFFAOYSA-N 0.000 description 3
• KMQWNQKESAHDKD-UHFFFAOYSA-N 2-chloro-4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C(Cl)=C1 KMQWNQKESAHDKD-UHFFFAOYSA-N 0.000 description 3
• FLBJVSACTWSENJ-UHFFFAOYSA-N 2-ethenyl-5-[3-(trifluoromethyl)phenoxy]pyridine Chemical compound FC(F)(F)C1=CC=CC(OC=2C=NC(C=C)=CC=2)=C1 FLBJVSACTWSENJ-UHFFFAOYSA-N 0.000 description 3
• GVORVQPNNSASDM-UHFFFAOYSA-N 3-chloro-4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1Cl GVORVQPNNSASDM-UHFFFAOYSA-N 0.000 description 3
• GKKJIQRJFFGEGR-UHFFFAOYSA-N 3-fluoro-4-[6-(trifluoromethyl)pyridin-3-yl]oxybenzaldehyde Chemical compound FC1=CC(C=O)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 GKKJIQRJFFGEGR-UHFFFAOYSA-N 0.000 description 3
• IOESVCKVAYUXEZ-UHFFFAOYSA-N 3-fluoro-4-pyrimidin-5-yloxybenzaldehyde Chemical compound FC1=CC(C=O)=CC=C1OC1=CN=CN=C1 IOESVCKVAYUXEZ-UHFFFAOYSA-N 0.000 description 3
• FEAIQXYYLIXIGJ-UHFFFAOYSA-N 4-[3-(trifluoromethyl)phenoxy]benzaldehyde Chemical compound FC(F)(F)C1=CC=CC(OC=2C=CC(C=O)=CC=2)=C1 FEAIQXYYLIXIGJ-UHFFFAOYSA-N 0.000 description 3
• PRYWVXRFNZLRKO-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)phenoxy]benzaldehyde Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=CC(C=O)=CC=2)=C1 PRYWVXRFNZLRKO-UHFFFAOYSA-N 0.000 description 3
• FJFJZCSDOGXEEQ-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)phenoxy]phenol Chemical compound C1=CC(O)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 FJFJZCSDOGXEEQ-UHFFFAOYSA-N 0.000 description 3
• DHPCRFYUUWAGAH-UHFFFAOYSA-N 4-fluoro-3-(trifluoromethyl)phenol Chemical compound OC1=CC=C(F)C(C(F)(F)F)=C1 DHPCRFYUUWAGAH-UHFFFAOYSA-N 0.000 description 3
• OVRKWGBQKLHFCM-UHFFFAOYSA-N 5-(2-cyano-4-formylphenoxy)pyridine-3-carbonitrile Chemical compound N#CC1=CC(C=O)=CC=C1OC1=CN=CC(C#N)=C1 OVRKWGBQKLHFCM-UHFFFAOYSA-N 0.000 description 3
• PIFDRSUIEWVYCO-UHFFFAOYSA-N 5-(hydroxymethyl)-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound N#CC1=CC(CO)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 PIFDRSUIEWVYCO-UHFFFAOYSA-N 0.000 description 3
• RVWYQSNFCNBIBK-UHFFFAOYSA-N 5-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[2-(trifluoromethyl)pyrimidin-5-yl]oxybenzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CN=C(C(F)(F)F)N=C1 RVWYQSNFCNBIBK-UHFFFAOYSA-N 0.000 description 3
• HIVZOSXHEVHIKK-UHFFFAOYSA-N 5-[2-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxy]ethyl]-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(C=C1C#N)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 HIVZOSXHEVHIKK-UHFFFAOYSA-N 0.000 description 3
• DDGWOYWIMKTSFK-UHFFFAOYSA-N 5-[2-cyano-4-(methylaminomethyl)phenoxy]pyridine-3-carbonitrile Chemical compound N#CC1=CC(CNC)=CC=C1OC1=CN=CC(C#N)=C1 DDGWOYWIMKTSFK-UHFFFAOYSA-N 0.000 description 3
• PGTLFIGYEWNNOH-UHFFFAOYSA-N 5-[4-chloro-3-(trifluoromethyl)phenoxy]-2-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C(=C1)C#N)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 PGTLFIGYEWNNOH-UHFFFAOYSA-N 0.000 description 3
• CXGHNEPJXIRAMK-UHFFFAOYSA-N 5-bromo-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(Br)=CC=2)C#N)=C1 CXGHNEPJXIRAMK-UHFFFAOYSA-N 0.000 description 3
• KZIXVFDDFIEDPM-UHFFFAOYSA-N 5-ethenyl-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(C=C)=CC=2)C#N)=C1 KZIXVFDDFIEDPM-UHFFFAOYSA-N 0.000 description 3
• MYTHQALSZXBUFW-UHFFFAOYSA-N 5-ethenyl-2-[5-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound FC(F)(F)C1=CN=CC(OC=2C(=CC(C=C)=CC=2)C#N)=C1 MYTHQALSZXBUFW-UHFFFAOYSA-N 0.000 description 3
• RPJYEVANEOGLFM-UHFFFAOYSA-N 5-ethenyl-2-[6-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(C=C)=CC=2)C#N)=N1 RPJYEVANEOGLFM-UHFFFAOYSA-N 0.000 description 3
• HKPHHEYOHZUYLJ-UHFFFAOYSA-N 5-formyl-2-[5-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound FC(F)(F)C1=CN=CC(OC=2C(=CC(C=O)=CC=2)C#N)=C1 HKPHHEYOHZUYLJ-UHFFFAOYSA-N 0.000 description 3
• KWNIOHMFTIPUMU-UHFFFAOYSA-N 5-hydroxy-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound N#CC1=CC(O)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 KWNIOHMFTIPUMU-UHFFFAOYSA-N 0.000 description 3
• YRRBATAVUCSTRH-UHFFFAOYSA-N 6-methoxy-1-methyl-3,4-dihydroisoquinoline Chemical compound CC1=NCCC2=CC(OC)=CC=C21 YRRBATAVUCSTRH-UHFFFAOYSA-N 0.000 description 3
• XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
• 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 3
• 208000023105 Huntington disease Diseases 0.000 description 3
• OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 3
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
• 108010007622 LDL Lipoproteins Proteins 0.000 description 3
• 102000007330 LDL Lipoproteins Human genes 0.000 description 3
• 102000004882 Lipase Human genes 0.000 description 3
• 108090001060 Lipase Proteins 0.000 description 3
• 239000004367 Lipase Substances 0.000 description 3
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
• 208000012902 Nervous system disease Diseases 0.000 description 3
• 108010064785 Phospholipases Proteins 0.000 description 3
• 102000015439 Phospholipases Human genes 0.000 description 3
• 108010058864 Phospholipases A2 Proteins 0.000 description 3
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
• GQJRPAPJNHJTEF-UHFFFAOYSA-N [3-chloro-4-(6-methylpyridin-3-yl)oxyphenyl]methanol Chemical compound C1=NC(C)=CC=C1OC1=CC=C(CO)C=C1Cl GQJRPAPJNHJTEF-UHFFFAOYSA-N 0.000 description 3
• FGLMWRBVASUUSP-UHFFFAOYSA-N [3-fluoro-4-[6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methanol Chemical compound FC1=CC(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 FGLMWRBVASUUSP-UHFFFAOYSA-N 0.000 description 3
• UVGWCEBINPBZFQ-UHFFFAOYSA-N [5-[3-(trifluoromethyl)phenoxy]pyridin-2-yl]methanol Chemical compound C1=NC(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 UVGWCEBINPBZFQ-UHFFFAOYSA-N 0.000 description 3
• LTCGTNNRQVPGNK-UHFFFAOYSA-N [5-[4-chloro-3-(trifluoromethyl)phenoxy]pyridin-2-yl]methanol Chemical compound C1=NC(CO)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 LTCGTNNRQVPGNK-UHFFFAOYSA-N 0.000 description 3
• 239000004480 active ingredient Substances 0.000 description 3
• 125000003342 alkenyl group Chemical group 0.000 description 3
• 125000000304 alkynyl group Chemical group 0.000 description 3
• 239000011230 binding agent Substances 0.000 description 3
• 210000004204 blood vessel Anatomy 0.000 description 3
• 230000037182 bone density Effects 0.000 description 3
• 210000002805 bone matrix Anatomy 0.000 description 3
• 239000002775 capsule Substances 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 3
• 238000004587 chromatography analysis Methods 0.000 description 3
• 229940125773 compound 10 Drugs 0.000 description 3
• 229940125758 compound 15 Drugs 0.000 description 3
• 229940126214 compound 3 Drugs 0.000 description 3
• 125000000753 cycloalkyl group Chemical group 0.000 description 3
• 231100000433 cytotoxic Toxicity 0.000 description 3
• 230000001472 cytotoxic effect Effects 0.000 description 3
• 230000007423 decrease Effects 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Substances CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 3
• 238000007865 diluting Methods 0.000 description 3
• 239000003085 diluting agent Substances 0.000 description 3
• WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 3
• 239000007884 disintegrant Substances 0.000 description 3
• 208000035475 disorder Diseases 0.000 description 3
• 239000000839 emulsion Substances 0.000 description 3
• 210000002889 endothelial cell Anatomy 0.000 description 3
• 239000000945 filler Substances 0.000 description 3
• 239000012458 free base Substances 0.000 description 3
• 125000005842 heteroatom Chemical group 0.000 description 3
• 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 3
• 239000005457 ice water Substances 0.000 description 3
• 229910052500 inorganic mineral Inorganic materials 0.000 description 3
• 208000028867 ischemia Diseases 0.000 description 3
• 238000002955 isolation Methods 0.000 description 3
• ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 3
• 239000010410 layer Substances 0.000 description 3
• 235000019421 lipase Nutrition 0.000 description 3
• 239000000314 lubricant Substances 0.000 description 3
• 210000004698 lymphocyte Anatomy 0.000 description 3
• 210000002540 macrophage Anatomy 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• LSEFCHWGJNHZNT-UHFFFAOYSA-M methyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 LSEFCHWGJNHZNT-UHFFFAOYSA-M 0.000 description 3
• 235000010755 mineral Nutrition 0.000 description 3
• 239000011707 mineral Substances 0.000 description 3
• 210000001616 monocyte Anatomy 0.000 description 3
• 239000008184 oral solid dosage form Substances 0.000 description 3
• 210000000056 organ Anatomy 0.000 description 3
• WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 3
• 238000011533 pre-incubation Methods 0.000 description 3
• 230000009467 reduction Effects 0.000 description 3
• 238000010992 reflux Methods 0.000 description 3
• 239000012047 saturated solution Substances 0.000 description 3
• 239000012279 sodium borohydride Substances 0.000 description 3
• 229910000033 sodium borohydride Inorganic materials 0.000 description 3
• SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 description 3
• 239000012453 solvate Substances 0.000 description 3
• 238000003756 stirring Methods 0.000 description 3
• 239000000126 substance Substances 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 208000024891 symptom Diseases 0.000 description 3
• 208000011580 syndromic disease Diseases 0.000 description 3
• 238000003786 synthesis reaction Methods 0.000 description 3
• 239000003826 tablet Substances 0.000 description 3
• 229940124597 therapeutic agent Drugs 0.000 description 3
• 230000001225 therapeutic effect Effects 0.000 description 3
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
• 229910052727 yttrium Inorganic materials 0.000 description 3
• SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 2
• DZOMRYLZWBYFLF-UHFFFAOYSA-N (2-acetyloxy-3-octadecylsulfanylpropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCCCCSCC(OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C DZOMRYLZWBYFLF-UHFFFAOYSA-N 0.000 description 2
• GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 2
• 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 2
• KBFFXDRANASBGL-UHFFFAOYSA-N 1-[2-(3-methoxyphenyl)ethyl]-1,3-diazinane-2,4,6-trione Chemical compound COC1=CC=CC(CCN2C(NC(=O)CC2=O)=O)=C1 KBFFXDRANASBGL-UHFFFAOYSA-N 0.000 description 2
• 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 description 2
• KBGFCBNZQULUDE-UHFFFAOYSA-N 1-chloro-4-(4-ethenylphenoxy)-2-(trifluoromethyl)benzene Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=CC(C=C)=CC=2)=C1 KBGFCBNZQULUDE-UHFFFAOYSA-N 0.000 description 2
• FXNAEFKHDCPOCW-UHFFFAOYSA-N 1-chloro-4-[4-(chloromethyl)phenoxy]-2-(trifluoromethyl)benzene Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=CC(CCl)=CC=2)=C1 FXNAEFKHDCPOCW-UHFFFAOYSA-N 0.000 description 2
• PIKVRSWADKJMTF-UHFFFAOYSA-N 1-chloro-4-[4-[chloro(difluoro)methyl]phenoxy]-2-(trifluoromethyl)benzene Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=CC(=CC=2)C(F)(F)Cl)=C1 PIKVRSWADKJMTF-UHFFFAOYSA-N 0.000 description 2
• JIIIHGCAPMRFHD-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)-5-(2-methoxyethenyl)pyridine Chemical compound N1=CC(C=COC)=CC=C1OC1=CC=C(F)C=C1F JIIIHGCAPMRFHD-UHFFFAOYSA-N 0.000 description 2
• WCHMYCOJRHCHAK-UHFFFAOYSA-N 2-(2-bromo-5-fluorophenyl)ethanol Chemical compound OCCC1=CC(F)=CC=C1Br WCHMYCOJRHCHAK-UHFFFAOYSA-N 0.000 description 2
• PVDAGKNKQFWQDO-UHFFFAOYSA-N 2-(2-bromophenoxy)oxane Chemical compound BrC1=CC=CC=C1OC1OCCCC1 PVDAGKNKQFWQDO-UHFFFAOYSA-N 0.000 description 2
• WJBMRZAHTUFBGE-UHFFFAOYSA-N 2-(3-methoxyphenyl)ethanamine Chemical compound COC1=CC=CC(CCN)=C1 WJBMRZAHTUFBGE-UHFFFAOYSA-N 0.000 description 2
• JBXFQDZSXIJTOM-UHFFFAOYSA-N 2-(4-pyrimidin-5-yloxyphenyl)acetaldehyde Chemical compound C1=CC(CC=O)=CC=C1OC1=CN=CN=C1 JBXFQDZSXIJTOM-UHFFFAOYSA-N 0.000 description 2
• RSBZICRILIQOFK-UHFFFAOYSA-N 2-(4-pyrimidin-5-yloxyphenyl)ethanol Chemical compound C1=CC(CCO)=CC=C1OC1=CN=CN=C1 RSBZICRILIQOFK-UHFFFAOYSA-N 0.000 description 2
• FPLUYXZGJKVWSY-UHFFFAOYSA-N 2-(5-chloropyridin-2-yl)oxy-5-formylbenzonitrile Chemical compound N1=CC(Cl)=CC=C1OC1=CC=C(C=O)C=C1C#N FPLUYXZGJKVWSY-UHFFFAOYSA-N 0.000 description 2
• BQSVBZGKANYSPD-UHFFFAOYSA-N 2-(5-chloropyridin-3-yl)oxy-5-(hydroxymethyl)benzonitrile Chemical compound N#CC1=CC(CO)=CC=C1OC1=CN=CC(Cl)=C1 BQSVBZGKANYSPD-UHFFFAOYSA-N 0.000 description 2
• DKNTUYBHYIJINO-UHFFFAOYSA-N 2-(5-chloropyridin-3-yl)oxy-5-(methylaminomethyl)benzonitrile Chemical compound N#CC1=CC(CNC)=CC=C1OC1=CN=CC(Cl)=C1 DKNTUYBHYIJINO-UHFFFAOYSA-N 0.000 description 2
• XRQGLVNSVPQCCQ-UHFFFAOYSA-N 2-(dibromomethyl)-5-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C=C(C(C(Br)Br)=CC=2)C#N)=C1 XRQGLVNSVPQCCQ-UHFFFAOYSA-N 0.000 description 2
• LDAFTDZWNFRXGG-UHFFFAOYSA-N 2-(trifluoromethyl)-1,4,5,6-tetrahydropyrimidin-5-ol Chemical compound OC1CNC(C(F)(F)F)=NC1 LDAFTDZWNFRXGG-UHFFFAOYSA-N 0.000 description 2
• SZPLGCRTLCAHSG-UHFFFAOYSA-N 2-(trifluoromethyl)-4-[3-(trifluoromethyl)phenoxy]benzaldehyde Chemical compound FC(F)(F)C1=CC=CC(OC=2C=C(C(C=O)=CC=2)C(F)(F)F)=C1 SZPLGCRTLCAHSG-UHFFFAOYSA-N 0.000 description 2
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
• YYTRTXWJGWACAY-UHFFFAOYSA-N 2-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-5-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C(=C1)C#N)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 YYTRTXWJGWACAY-UHFFFAOYSA-N 0.000 description 2
• UZMNEWMJTLYKTG-UHFFFAOYSA-N 2-[2-fluoro-4-(2-methoxyethenyl)phenoxy]-6-(trifluoromethyl)pyridine Chemical compound FC1=CC(C=COC)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 UZMNEWMJTLYKTG-UHFFFAOYSA-N 0.000 description 2
• JARRATCOGSRERN-UHFFFAOYSA-N 2-[3-chloro-4-(trifluoromethyl)phenoxy]-5-(methylaminomethyl)benzonitrile Chemical compound N#CC1=CC(CNC)=CC=C1OC1=CC=C(C(F)(F)F)C(Cl)=C1 JARRATCOGSRERN-UHFFFAOYSA-N 0.000 description 2
• OBFSLFDEGXLIQA-UHFFFAOYSA-N 2-[3-fluoro-4-[6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]acetaldehyde Chemical compound FC1=CC(CC=O)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 OBFSLFDEGXLIQA-UHFFFAOYSA-N 0.000 description 2
• DNLRIVBCGBOIHN-UHFFFAOYSA-N 2-[3-fluoro-4-[6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]ethanol Chemical compound FC1=CC(CCO)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 DNLRIVBCGBOIHN-UHFFFAOYSA-N 0.000 description 2
• PSZXARGKACRDRE-UHFFFAOYSA-N 2-[3-fluoro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]acetaldehyde Chemical compound FC1=CC(CC=O)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 PSZXARGKACRDRE-UHFFFAOYSA-N 0.000 description 2
• GFQJQLGUQXAVBG-UHFFFAOYSA-N 2-[3-fluoro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]ethanol Chemical compound FC1=CC(CCO)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 GFQJQLGUQXAVBG-UHFFFAOYSA-N 0.000 description 2
• TZOBSHHUEFVXAO-UHFFFAOYSA-N 2-[4-[4-chloro-3-(trifluoromethyl)phenoxy]phenoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OC(C=C1)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 TZOBSHHUEFVXAO-UHFFFAOYSA-N 0.000 description 2
• KOGJRWLMIOGPRO-UHFFFAOYSA-N 2-[4-[4-chloro-3-(trifluoromethyl)phenoxy]phenyl]ethanol Chemical compound C1=CC(CCO)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 KOGJRWLMIOGPRO-UHFFFAOYSA-N 0.000 description 2
• IHPDVNNTJBPBRP-UHFFFAOYSA-N 2-[4-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]ethanol Chemical compound C1=CC(CCO)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 IHPDVNNTJBPBRP-UHFFFAOYSA-N 0.000 description 2
• JPIFGGLUPURPIV-UHFFFAOYSA-N 2-[4-chloro-3-(trifluoromethyl)phenoxy]-5-(2-hydroxyethyl)benzonitrile Chemical compound N#CC1=CC(CCO)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 JPIFGGLUPURPIV-UHFFFAOYSA-N 0.000 description 2
• GEVQHFOXUSUVLE-UHFFFAOYSA-N 2-[4-chloro-3-(trifluoromethyl)phenoxy]-5-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 GEVQHFOXUSUVLE-UHFFFAOYSA-N 0.000 description 2
• GFMSEJBKNAOORZ-UHFFFAOYSA-N 2-[4-chloro-3-(trifluoromethyl)phenoxy]-5-[(9-methyl-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]benzonitrile Chemical compound C=1C(C)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 GFMSEJBKNAOORZ-UHFFFAOYSA-N 0.000 description 2
• OHVISZDAPADSBP-UHFFFAOYSA-N 2-[4-chloro-3-(trifluoromethyl)phenoxy]-5-[2-[(9-fluoro-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxy]ethyl]benzonitrile Chemical compound C=1C(F)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(C=C1C#N)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 OHVISZDAPADSBP-UHFFFAOYSA-N 0.000 description 2
• XHLVOCFHNYHNJR-UHFFFAOYSA-N 2-[4-chloro-3-(trifluoromethyl)phenoxy]-5-ethenylbenzonitrile Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C(=CC(C=C)=CC=2)C#N)=C1 XHLVOCFHNYHNJR-UHFFFAOYSA-N 0.000 description 2
• YBZFTRVDYHAYTN-UHFFFAOYSA-N 2-[4-fluoro-2-[2-(oxan-2-yloxy)ethyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(F)C=C1CCOC1OCCCC1 YBZFTRVDYHAYTN-UHFFFAOYSA-N 0.000 description 2
• MHJUTYGESLHPKO-UHFFFAOYSA-N 2-[4-fluoro-3-(trifluoromethyl)phenoxy]-5-(hydroxymethyl)benzonitrile Chemical compound N#CC1=CC(CO)=CC=C1OC1=CC=C(F)C(C(F)(F)F)=C1 MHJUTYGESLHPKO-UHFFFAOYSA-N 0.000 description 2
• ZRYBVOINIDUVLE-UHFFFAOYSA-N 2-[4-fluoro-3-(trifluoromethyl)phenoxy]-5-formylbenzonitrile Chemical compound C1=C(C(F)(F)F)C(F)=CC=C1OC1=CC=C(C=O)C=C1C#N ZRYBVOINIDUVLE-UHFFFAOYSA-N 0.000 description 2
• XLQKYSZWQRUAHE-UHFFFAOYSA-N 2-[5-[3-(trifluoromethyl)phenoxy]pyridin-2-yl]ethanol Chemical compound C1=NC(CCO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 XLQKYSZWQRUAHE-UHFFFAOYSA-N 0.000 description 2
• JFBNTGNBFJGHNP-UHFFFAOYSA-N 2-[5-[4-chloro-3-(trifluoromethyl)phenoxy]pyridin-2-yl]ethanol Chemical compound C1=NC(CCO)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 JFBNTGNBFJGHNP-UHFFFAOYSA-N 0.000 description 2
• ZVMYHDVETXMHPV-UHFFFAOYSA-N 2-[5-[4-fluoro-3-(trifluoromethyl)phenoxy]pyridin-2-yl]ethanol Chemical compound C1=NC(CCO)=CC=C1OC1=CC=C(F)C(C(F)(F)F)=C1 ZVMYHDVETXMHPV-UHFFFAOYSA-N 0.000 description 2
• HWBQQJNSGKLUNA-UHFFFAOYSA-N 2-[6-(2,4-difluorophenoxy)pyridin-3-yl]acetaldehyde Chemical compound FC1=CC(F)=CC=C1OC1=CC=C(CC=O)C=N1 HWBQQJNSGKLUNA-UHFFFAOYSA-N 0.000 description 2
• SOGBLHUJGHEXAI-UHFFFAOYSA-N 2-[6-(2,4-difluorophenoxy)pyridin-3-yl]ethanol Chemical compound N1=CC(CCO)=CC=C1OC1=CC=C(F)C=C1F SOGBLHUJGHEXAI-UHFFFAOYSA-N 0.000 description 2
• NUZBQMSTVIBMNE-UHFFFAOYSA-N 2-[6-[4-chloro-3-(trifluoromethyl)phenoxy]pyridin-3-yl]ethanol Chemical compound N1=CC(CCO)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 NUZBQMSTVIBMNE-UHFFFAOYSA-N 0.000 description 2
• KDUORLUGTVWWLQ-UHFFFAOYSA-N 2-[[3-chloro-4-(6-methylpyridin-3-yl)oxyphenyl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1Cl)=CC=C1OC1=CC=C(C)N=C1 KDUORLUGTVWWLQ-UHFFFAOYSA-N 0.000 description 2
• GJFYGPSPJUZYBL-UHFFFAOYSA-N 2-[[3-fluoro-4-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methoxy]-9-methyl-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(C)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 GJFYGPSPJUZYBL-UHFFFAOYSA-N 0.000 description 2
• MQEOAYDTJHMWLT-UHFFFAOYSA-N 2-[[3-fluoro-4-[6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound FC1=CC(COC2=NC(=O)N3CCC4=CC=CC=C4C3=C2)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 MQEOAYDTJHMWLT-UHFFFAOYSA-N 0.000 description 2
• QDDQGBXLITZZOJ-UHFFFAOYSA-N 2-[[4-[4-chloro-3-(trifluoromethyl)phenoxy]phenyl]methyl]isoindole-1,3-dione Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=CC(CN3C(C4=CC=CC=C4C3=O)=O)=CC=2)=C1 QDDQGBXLITZZOJ-UHFFFAOYSA-N 0.000 description 2
• CAJNHXNTJCPXQL-UHFFFAOYSA-N 2-[[6-[4-chloro-3-(trifluoromethyl)phenoxy]-5-fluoropyridin-3-yl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CN=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 CAJNHXNTJCPXQL-UHFFFAOYSA-N 0.000 description 2
• 108700003842 2-acetyl-S-octadecyl-1-thioglycero-3-phosphocholine Proteins 0.000 description 2
• UENGBOCGGKLVJJ-UHFFFAOYSA-N 2-chloro-1-(2,4-difluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CCl)C(F)=C1 UENGBOCGGKLVJJ-UHFFFAOYSA-N 0.000 description 2
• PMRKVQAQMZBBIQ-UHFFFAOYSA-N 2-chloro-4-[3-(trifluoromethyl)phenoxy]benzaldehyde Chemical compound FC(F)(F)C1=CC=CC(OC=2C=C(Cl)C(C=O)=CC=2)=C1 PMRKVQAQMZBBIQ-UHFFFAOYSA-N 0.000 description 2
• QFIKILDYGFBYKB-UHFFFAOYSA-N 2-chloro-4-[4-chloro-3-(trifluoromethyl)phenoxy]benzaldehyde Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=C(Cl)C(C=O)=CC=2)=C1 QFIKILDYGFBYKB-UHFFFAOYSA-N 0.000 description 2
• LGVGUHQFJYLMQE-UHFFFAOYSA-N 2-chloro-4-[6-(trifluoromethyl)pyridin-3-yl]oxybenzaldehyde Chemical compound C1=NC(C(F)(F)F)=CC=C1OC1=CC=C(C=O)C(Cl)=C1 LGVGUHQFJYLMQE-UHFFFAOYSA-N 0.000 description 2
• JFZJMSDDOOAOIV-UHFFFAOYSA-N 2-chloro-5-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)N=C1 JFZJMSDDOOAOIV-UHFFFAOYSA-N 0.000 description 2
• ABQSSRAUEAMFTR-UHFFFAOYSA-N 2-ethenyl-5-[4-fluoro-3-(trifluoromethyl)phenoxy]pyridine Chemical compound C1=C(C(F)(F)F)C(F)=CC=C1OC1=CC=C(C=C)N=C1 ABQSSRAUEAMFTR-UHFFFAOYSA-N 0.000 description 2
• AOHHQFNAFKAQRD-UHFFFAOYSA-N 2-formyl-5-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C=C(C(C=O)=CC=2)C#N)=C1 AOHHQFNAFKAQRD-UHFFFAOYSA-N 0.000 description 2
• LWXJFPSARBURQS-UHFFFAOYSA-N 2-hydroxy-5-iodobenzonitrile Chemical compound OC1=CC=C(I)C=C1C#N LWXJFPSARBURQS-UHFFFAOYSA-N 0.000 description 2
• GXBRSXLVXKWHAH-UHFFFAOYSA-N 2-hydroxy-9-methoxy-6,7-dihydrobenzo[a]quinolizin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN1C2=CC(O)=CC1=O GXBRSXLVXKWHAH-UHFFFAOYSA-N 0.000 description 2
• IEGPNPNFECVXKL-UHFFFAOYSA-N 2-methyl-5-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound C1=C(C#N)C(C)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 IEGPNPNFECVXKL-UHFFFAOYSA-N 0.000 description 2
• NLAVHUUABUFSIG-UHFFFAOYSA-N 3,4,5-trifluorobenzaldehyde Chemical compound FC1=CC(C=O)=CC(F)=C1F NLAVHUUABUFSIG-UHFFFAOYSA-N 0.000 description 2
• CVRBKRJSBBCUGO-UHFFFAOYSA-N 3,5-difluoro-4-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC1=CC(C#N)=CC(F)=C1OC1=CC=CC(C(F)(F)F)=C1 CVRBKRJSBBCUGO-UHFFFAOYSA-N 0.000 description 2
• LJVMILOOUPMJHG-UHFFFAOYSA-N 3-(trifluoromethyl)-4-[3-(trifluoromethyl)phenoxy]benzaldehyde Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(C=O)=CC=2)C(F)(F)F)=C1 LJVMILOOUPMJHG-UHFFFAOYSA-N 0.000 description 2
• SQKLWSYZULMSDZ-UHFFFAOYSA-N 3-bromo-4-[3-(trifluoromethyl)phenoxy]benzaldehyde Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(C=O)=CC=2)Br)=C1 SQKLWSYZULMSDZ-UHFFFAOYSA-N 0.000 description 2
• RONUIEMMOPZTLU-UHFFFAOYSA-N 3-chloro-4-(6-methylpyridin-3-yl)oxybenzaldehyde Chemical compound C1=NC(C)=CC=C1OC1=CC=C(C=O)C=C1Cl RONUIEMMOPZTLU-UHFFFAOYSA-N 0.000 description 2
• WZFDRJMYHWUGSI-UHFFFAOYSA-N 3-chloro-4-[3-(trifluoromethyl)phenoxy]benzaldehyde Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(C=O)=CC=2)Cl)=C1 WZFDRJMYHWUGSI-UHFFFAOYSA-N 0.000 description 2
• ICEBNDHTZFQTEV-UHFFFAOYSA-N 3-fluoro-4-[2-(trifluoromethyl)pyrimidin-5-yl]oxybenzaldehyde Chemical compound FC1=CC(C=O)=CC=C1OC1=CN=C(C(F)(F)F)N=C1 ICEBNDHTZFQTEV-UHFFFAOYSA-N 0.000 description 2
• DQQKHICEERQDTJ-UHFFFAOYSA-N 3-fluoro-4-[3-(trifluoromethyl)phenoxy]benzaldehyde Chemical compound FC1=CC(C=O)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 DQQKHICEERQDTJ-UHFFFAOYSA-N 0.000 description 2
• OFUFNVKKUPZTJV-UHFFFAOYSA-N 3-fluoro-4-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC1=CC(C#N)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 OFUFNVKKUPZTJV-UHFFFAOYSA-N 0.000 description 2
• XIBCIKHMJOMJRQ-UHFFFAOYSA-N 3-methoxy-4-[3-(trifluoromethyl)phenoxy]benzaldehyde Chemical compound COC1=CC(C=O)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 XIBCIKHMJOMJRQ-UHFFFAOYSA-N 0.000 description 2
• FULBGTRKCLFETF-UHFFFAOYSA-N 3-methyl-4-[3-(trifluoromethyl)phenoxy]benzaldehyde Chemical compound CC1=CC(C=O)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 FULBGTRKCLFETF-UHFFFAOYSA-N 0.000 description 2
• OXCFWRVTTLSOGH-UHFFFAOYSA-N 3-phenylmethoxy-5-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CN=CC(OCC=2C=CC=CC=2)=C1 OXCFWRVTTLSOGH-UHFFFAOYSA-N 0.000 description 2
• GRFNBEZIAWKNCO-UHFFFAOYSA-N 3-pyridinol Chemical compound OC1=CC=CN=C1 GRFNBEZIAWKNCO-UHFFFAOYSA-N 0.000 description 2
• GKPVSCTZMGCGRS-UHFFFAOYSA-N 4-(5-chloropyridin-2-yl)oxy-3-fluorobenzaldehyde Chemical compound FC1=CC(C=O)=CC=C1OC1=CC=C(Cl)C=N1 GKPVSCTZMGCGRS-UHFFFAOYSA-N 0.000 description 2
• NQXXCSJNJICNGR-UHFFFAOYSA-N 4-(5-chloropyridin-3-yl)oxybenzaldehyde Chemical compound ClC1=CN=CC(OC=2C=CC(C=O)=CC=2)=C1 NQXXCSJNJICNGR-UHFFFAOYSA-N 0.000 description 2
• JZAWDGBRUNVIOC-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)phenoxy]-2-(trifluoromethyl)benzaldehyde Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=C(C(C=O)=CC=2)C(F)(F)F)=C1 JZAWDGBRUNVIOC-UHFFFAOYSA-N 0.000 description 2
• SPDNABJYNDLVPT-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)phenoxy]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 SPDNABJYNDLVPT-UHFFFAOYSA-N 0.000 description 2
• NONOHEMDNFTKCZ-UHFFFAOYSA-N 4-fluoro-2-(trifluoromethyl)benzaldehyde Chemical compound FC1=CC=C(C=O)C(C(F)(F)F)=C1 NONOHEMDNFTKCZ-UHFFFAOYSA-N 0.000 description 2
• XLSZMDLNRCVEIJ-UHFFFAOYSA-N 4-methylimidazole Chemical compound CC1=CNC=N1 XLSZMDLNRCVEIJ-UHFFFAOYSA-N 0.000 description 2
• UFMGPLUKYBMTMX-UHFFFAOYSA-N 4-pyrimidin-5-yloxybenzaldehyde Chemical compound C1=CC(C=O)=CC=C1OC1=CN=CN=C1 UFMGPLUKYBMTMX-UHFFFAOYSA-N 0.000 description 2
• NWQZXOWZUQQACN-UHFFFAOYSA-N 5-(2,2-dimethoxyethyl)-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound N#CC1=CC(CC(OC)OC)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 NWQZXOWZUQQACN-UHFFFAOYSA-N 0.000 description 2
• YOXRRZVSFIKXLY-UHFFFAOYSA-N 5-(2-chloro-4-formylphenoxy)pyridine-3-carbonitrile Chemical compound ClC1=CC(C=O)=CC=C1OC1=CN=CC(C#N)=C1 YOXRRZVSFIKXLY-UHFFFAOYSA-N 0.000 description 2
• MKTIBTMPXRXZBN-UHFFFAOYSA-N 5-(2-fluoro-4-formylphenoxy)pyridine-3-carbonitrile Chemical compound FC1=CC(C=O)=CC=C1OC1=CN=CC(C#N)=C1 MKTIBTMPXRXZBN-UHFFFAOYSA-N 0.000 description 2
• NIQKPAPHALGEFL-UHFFFAOYSA-N 5-(2-hydroxyethyl)-2-[2-(trifluoromethyl)pyrimidin-5-yl]oxybenzonitrile Chemical compound N#CC1=CC(CCO)=CC=C1OC1=CN=C(C(F)(F)F)N=C1 NIQKPAPHALGEFL-UHFFFAOYSA-N 0.000 description 2
• FJYPLDGEAKPFFK-UHFFFAOYSA-N 5-(2-hydroxyethyl)-2-[5-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound N#CC1=CC(CCO)=CC=C1OC1=CN=CC(C(F)(F)F)=C1 FJYPLDGEAKPFFK-UHFFFAOYSA-N 0.000 description 2
• MUTJKWWBJIZCBP-UHFFFAOYSA-N 5-(2-methoxyethenyl)-2-[2-(trifluoromethyl)pyrimidin-5-yl]oxybenzonitrile Chemical compound N#CC1=CC(C=COC)=CC=C1OC1=CN=C(C(F)(F)F)N=C1 MUTJKWWBJIZCBP-UHFFFAOYSA-N 0.000 description 2
• ODQHEENBWHBYNY-UHFFFAOYSA-N 5-(2-oxoethyl)-2-[2-(trifluoromethyl)pyrimidin-5-yl]oxybenzonitrile Chemical compound C1=NC(C(F)(F)F)=NC=C1OC1=CC=C(CC=O)C=C1C#N ODQHEENBWHBYNY-UHFFFAOYSA-N 0.000 description 2
• CVZQCAQFCOMACV-UHFFFAOYSA-N 5-(2-oxoethyl)-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(CC=O)=CC=2)C#N)=C1 CVZQCAQFCOMACV-UHFFFAOYSA-N 0.000 description 2
• UAXGBEGXWQWHPZ-UHFFFAOYSA-N 5-(2-oxoethyl)-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound C1=NC(C(F)(F)F)=CC=C1OC1=CC=C(CC=O)C=C1C#N UAXGBEGXWQWHPZ-UHFFFAOYSA-N 0.000 description 2
• XQEFYTAGPCEVRM-UHFFFAOYSA-N 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound O1C(C)(C)C(C)(C)OB1C(C=C1C#N)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 XQEFYTAGPCEVRM-UHFFFAOYSA-N 0.000 description 2
• SFOOZDJICLEVQU-UHFFFAOYSA-N 5-(4-formylphenoxy)pyridine-3-carbonitrile Chemical compound C1=CC(C=O)=CC=C1OC1=CN=CC(C#N)=C1 SFOOZDJICLEVQU-UHFFFAOYSA-N 0.000 description 2
• IPZSBXOHLVZHKV-UHFFFAOYSA-N 5-(aminomethyl)-2-(5-chloropyridin-3-yl)oxybenzonitrile Chemical compound N#CC1=CC(CN)=CC=C1OC1=CN=CC(Cl)=C1 IPZSBXOHLVZHKV-UHFFFAOYSA-N 0.000 description 2
• XDCIOFPXOJUQFV-UHFFFAOYSA-N 5-(aminomethyl)-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound N#CC1=CC(CN)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 XDCIOFPXOJUQFV-UHFFFAOYSA-N 0.000 description 2
• TYYBIMBFKBUIPU-UHFFFAOYSA-N 5-(difluoromethyl)-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound N#CC1=CC(C(F)F)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 TYYBIMBFKBUIPU-UHFFFAOYSA-N 0.000 description 2
• DZFIHGKPOVEFMI-UHFFFAOYSA-N 5-(hydroxymethyl)-2-(6-methylpyridin-3-yl)oxybenzonitrile Chemical compound C1=NC(C)=CC=C1OC1=CC=C(CO)C=C1C#N DZFIHGKPOVEFMI-UHFFFAOYSA-N 0.000 description 2
• NZMGCPVEDOOYHU-UHFFFAOYSA-N 5-(hydroxymethyl)-2-[2-(trifluoromethyl)pyrimidin-5-yl]oxybenzonitrile Chemical compound N#CC1=CC(CO)=CC=C1OC1=CN=C(C(F)(F)F)N=C1 NZMGCPVEDOOYHU-UHFFFAOYSA-N 0.000 description 2
• GULLINSFBLCLGP-UHFFFAOYSA-N 5-(hydroxymethyl)-2-[5-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound N#CC1=CC(CO)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 GULLINSFBLCLGP-UHFFFAOYSA-N 0.000 description 2
• JHOCKFVSAWCSPD-UHFFFAOYSA-N 5-(hydroxymethyl)-2-[5-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound N#CC1=CC(CO)=CC=C1OC1=CN=CC(C(F)(F)F)=C1 JHOCKFVSAWCSPD-UHFFFAOYSA-N 0.000 description 2
• VQYMYIOTTDUIMD-UHFFFAOYSA-N 5-(hydroxymethyl)-2-pyridin-3-yloxybenzonitrile Chemical compound N#CC1=CC(CO)=CC=C1OC1=CC=CN=C1 VQYMYIOTTDUIMD-UHFFFAOYSA-N 0.000 description 2
• RQLLEQOOMMLDJF-UHFFFAOYSA-N 5-(hydroxymethyl)-2-pyrimidin-5-yloxybenzonitrile Chemical compound N#CC1=CC(CO)=CC=C1OC1=CN=CN=C1 RQLLEQOOMMLDJF-UHFFFAOYSA-N 0.000 description 2
• NTPJQZOBRLFFMH-UHFFFAOYSA-N 5-(sulfanylmethyl)-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(CS)=CC=2)C#N)=C1 NTPJQZOBRLFFMH-UHFFFAOYSA-N 0.000 description 2
• YUUZFMWMDPHTQS-UHFFFAOYSA-N 5-(trifluoromethyl)pyridin-3-ol Chemical compound OC1=CN=CC(C(F)(F)F)=C1 YUUZFMWMDPHTQS-UHFFFAOYSA-N 0.000 description 2
• MTYGQPOKNWIDRI-UHFFFAOYSA-N 5-[(1,3-dioxoisoindol-2-yl)methyl]-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(CN3C(C4=CC=CC=C4C3=O)=O)=CC=2)C#N)=C1 MTYGQPOKNWIDRI-UHFFFAOYSA-N 0.000 description 2
• PRPQSMNTWVMION-UHFFFAOYSA-N 5-[(9-fluoro-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound C=1C(F)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 PRPQSMNTWVMION-UHFFFAOYSA-N 0.000 description 2
• KBNDZENRCSHTJT-UHFFFAOYSA-N 5-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxy]-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OC(C=C1C#N)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 KBNDZENRCSHTJT-UHFFFAOYSA-N 0.000 description 2
• MZDZWXNMZCJOHU-UHFFFAOYSA-N 5-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[6-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 MZDZWXNMZCJOHU-UHFFFAOYSA-N 0.000 description 2
• OWZUUYCRFZYKLM-UHFFFAOYSA-N 5-[(9-methyl-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[6-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound C=1C(C)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 OWZUUYCRFZYKLM-UHFFFAOYSA-N 0.000 description 2
• BOISJLBMXMTWKO-UHFFFAOYSA-N 5-[2-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxy]ethyl]-2-[5-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(C=C1C#N)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 BOISJLBMXMTWKO-UHFFFAOYSA-N 0.000 description 2
• MNRFCMZGTBIUDO-UHFFFAOYSA-N 5-[2-chloro-4-(hydroxymethyl)phenoxy]pyridine-3-carbonitrile Chemical compound ClC1=CC(CO)=CC=C1OC1=CN=CC(C#N)=C1 MNRFCMZGTBIUDO-UHFFFAOYSA-N 0.000 description 2
• TUWKAAUHOZQDMT-UHFFFAOYSA-N 5-[2-cyano-4-(hydroxymethyl)phenoxy]pyridine-3-carbonitrile Chemical compound N#CC1=CC(CO)=CC=C1OC1=CN=CC(C#N)=C1 TUWKAAUHOZQDMT-UHFFFAOYSA-N 0.000 description 2
• SEZJTSNMRZHIPB-UHFFFAOYSA-N 5-[2-fluoro-4-(hydroxymethyl)phenoxy]pyridine-3-carbonitrile Chemical compound FC1=CC(CO)=CC=C1OC1=CN=CC(C#N)=C1 SEZJTSNMRZHIPB-UHFFFAOYSA-N 0.000 description 2
• BFSJBXJLOVFFJO-UHFFFAOYSA-N 5-[4-(hydroxymethyl)phenoxy]pyridine-3-carbonitrile Chemical compound C1=CC(CO)=CC=C1OC1=CN=CC(C#N)=C1 BFSJBXJLOVFFJO-UHFFFAOYSA-N 0.000 description 2
• XPWQMWALUPXCSB-UHFFFAOYSA-N 5-[4-chloro-3-(trifluoromethyl)phenoxy]-2-ethenylpyridine Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=NC(C=C)=CC=2)=C1 XPWQMWALUPXCSB-UHFFFAOYSA-N 0.000 description 2
• YIFPUFWUBRKGMG-UHFFFAOYSA-N 5-[4-chloro-3-(trifluoromethyl)phenoxy]-2-formylbenzonitrile Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=C(C(C=O)=CC=2)C#N)=C1 YIFPUFWUBRKGMG-UHFFFAOYSA-N 0.000 description 2
• KUOJEOLTSRPDGH-UHFFFAOYSA-N 5-[4-chloro-3-(trifluoromethyl)phenoxy]pyrimidine-2-carbaldehyde Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=NC(C=O)=NC=2)=C1 KUOJEOLTSRPDGH-UHFFFAOYSA-N 0.000 description 2
• PQTKTRQIVFQWSL-UHFFFAOYSA-N 5-[4-chloro-3-(trifluoromethyl)phenoxy]pyrimidine-2-carbonitrile Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=NC(=NC=2)C#N)=C1 PQTKTRQIVFQWSL-UHFFFAOYSA-N 0.000 description 2
• WQWOJQPJIRSJCY-UHFFFAOYSA-N 5-[chloro(difluoro)methyl]-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(=CC=2)C(F)(F)Cl)C#N)=C1 WQWOJQPJIRSJCY-UHFFFAOYSA-N 0.000 description 2
• ZPIUXXPRZFOKLX-UHFFFAOYSA-N 5-bromo-2-[4-chloro-3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C(=CC(Br)=CC=2)C#N)=C1 ZPIUXXPRZFOKLX-UHFFFAOYSA-N 0.000 description 2
• GYCNHFWRPJXTSB-UHFFFAOYSA-N 5-bromo-2-fluorobenzonitrile Chemical compound FC1=CC=C(Br)C=C1C#N GYCNHFWRPJXTSB-UHFFFAOYSA-N 0.000 description 2
• VNYBIBSZZDAEOK-UHFFFAOYSA-N 5-bromopyridin-3-ol Chemical compound OC1=CN=CC(Br)=C1 VNYBIBSZZDAEOK-UHFFFAOYSA-N 0.000 description 2
• SZFUWUOHDRMCKD-UHFFFAOYSA-N 5-chloro-1h-pyridin-2-one Chemical compound OC1=CC=C(Cl)C=N1 SZFUWUOHDRMCKD-UHFFFAOYSA-N 0.000 description 2
• TUIDQYRZDZRHPQ-UHFFFAOYSA-N 5-chloropyridin-3-ol Chemical compound OC1=CN=CC(Cl)=C1 TUIDQYRZDZRHPQ-UHFFFAOYSA-N 0.000 description 2
• YYLBDBOSXXSZQQ-UHFFFAOYSA-N 5-chloropyridine-2-carbaldehyde Chemical compound ClC1=CC=C(C=O)N=C1 YYLBDBOSXXSZQQ-UHFFFAOYSA-N 0.000 description 2
• ODQGUVCCJBPYCV-UHFFFAOYSA-N 5-ethenyl-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound C1=NC(C(F)(F)F)=CC=C1OC1=CC=C(C=C)C=C1C#N ODQGUVCCJBPYCV-UHFFFAOYSA-N 0.000 description 2
• ULPBXAXFGXYPHC-UHFFFAOYSA-N 5-fluoro-6-(4-fluorophenoxy)pyridine-3-carbaldehyde Chemical compound C1=CC(F)=CC=C1OC1=NC=C(C=O)C=C1F ULPBXAXFGXYPHC-UHFFFAOYSA-N 0.000 description 2
• NGNKTTOCKWGNGT-UHFFFAOYSA-N 5-fluoro-6-[3-(trifluoromethyl)phenoxy]pyridine-3-carbaldehyde Chemical compound FC1=CC(C=O)=CN=C1OC1=CC=CC(C(F)(F)F)=C1 NGNKTTOCKWGNGT-UHFFFAOYSA-N 0.000 description 2
• ROFSYUWJMSFYSX-UHFFFAOYSA-N 5-fluoro-6-[4-fluoro-3-(trifluoromethyl)phenoxy]pyridine-3-carbaldehyde Chemical compound C1=C(C(F)(F)F)C(F)=CC=C1OC1=NC=C(C=O)C=C1F ROFSYUWJMSFYSX-UHFFFAOYSA-N 0.000 description 2
• IACCXWQKIQUVFQ-UHFFFAOYSA-N 5-fluoropyridine-2-carbaldehyde Chemical compound FC1=CC=C(C=O)N=C1 IACCXWQKIQUVFQ-UHFFFAOYSA-N 0.000 description 2
• BHXHRMVSUUPOLX-UHFFFAOYSA-N 5-fluoropyridine-2-carbonitrile Chemical compound FC1=CC=C(C#N)N=C1 BHXHRMVSUUPOLX-UHFFFAOYSA-N 0.000 description 2
• SLJGHVLFAXDWGV-UHFFFAOYSA-N 5-formyl-2-(6-methylpyridin-3-yl)oxybenzonitrile Chemical compound C1=NC(C)=CC=C1OC1=CC=C(C=O)C=C1C#N SLJGHVLFAXDWGV-UHFFFAOYSA-N 0.000 description 2
• HEQRVYIVZXICMH-UHFFFAOYSA-N 5-formyl-2-[5-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound N1=CC(C(F)(F)F)=CC=C1OC1=CC=C(C=O)C=C1C#N HEQRVYIVZXICMH-UHFFFAOYSA-N 0.000 description 2
• LPAJLHXUOPBCOO-UHFFFAOYSA-N 5-formyl-2-pyrimidin-5-yloxybenzonitrile Chemical compound N#CC1=CC(C=O)=CC=C1OC1=CN=CN=C1 LPAJLHXUOPBCOO-UHFFFAOYSA-N 0.000 description 2
• QJYPEKRACVFCFF-UHFFFAOYSA-N 5-hydroxy-2-methylbenzonitrile Chemical compound CC1=CC=C(O)C=C1C#N QJYPEKRACVFCFF-UHFFFAOYSA-N 0.000 description 2
• WJWXTHTYRRBPLA-UHFFFAOYSA-N 5-iodo-2-[5-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound N1=CC(C(F)(F)F)=CC=C1OC1=CC=C(I)C=C1C#N WJWXTHTYRRBPLA-UHFFFAOYSA-N 0.000 description 2
• RXQIMSBNQMJDDQ-UHFFFAOYSA-N 5-phenylmethoxypyrimidine Chemical compound C=1C=CC=CC=1COC1=CN=CN=C1 RXQIMSBNQMJDDQ-UHFFFAOYSA-N 0.000 description 2
• QPQYAYRVSWAGBN-UHFFFAOYSA-N 6,7-dihydropyrimido[6,1-a]isoquinoline-2,4-dione Chemical compound C12=CC=CC=C2CCN2C1=CC(O)=NC2=O QPQYAYRVSWAGBN-UHFFFAOYSA-N 0.000 description 2
• BXCSVXYSJVOYGP-UHFFFAOYSA-N 6-(2,4-difluorophenoxy)pyridine-3-carbaldehyde Chemical compound FC1=CC(F)=CC=C1OC1=CC=C(C=O)C=N1 BXCSVXYSJVOYGP-UHFFFAOYSA-N 0.000 description 2
• PSGGOMYYKUTLTB-UHFFFAOYSA-N 6-[2-(2-hydroxyethyl)phenyl]-1h-pyrimidine-2,4-dione Chemical compound OCCC1=CC=CC=C1C1=CC(=O)NC(=O)N1 PSGGOMYYKUTLTB-UHFFFAOYSA-N 0.000 description 2
• KOZBVYPFNRRIOZ-UHFFFAOYSA-N 6-[2-[2-(oxan-2-yloxy)ethyl]phenyl]-1h-pyrimidine-2,4-dione Chemical compound N1C(=O)NC(=O)C=C1C1=CC=CC=C1CCOC1OCCCC1 KOZBVYPFNRRIOZ-UHFFFAOYSA-N 0.000 description 2
• DRUGLLSGNJQMBN-UHFFFAOYSA-N 6-[3-(trifluoromethyl)phenoxy]pyridine-3-carbaldehyde Chemical compound FC(F)(F)C1=CC=CC(OC=2N=CC(C=O)=CC=2)=C1 DRUGLLSGNJQMBN-UHFFFAOYSA-N 0.000 description 2
• VZUCPPVFAQHBGE-UHFFFAOYSA-N 6-[4-chloro-3-(trifluoromethyl)phenoxy]-5-fluoropyridine-3-carbaldehyde Chemical compound FC1=CC(C=O)=CN=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 VZUCPPVFAQHBGE-UHFFFAOYSA-N 0.000 description 2
• YDQTWCVCCXQCGZ-UHFFFAOYSA-N 6-[4-fluoro-2-[2-(oxan-2-yloxy)ethyl]phenyl]-1h-pyrimidine-2,4-dione Chemical compound C=1C(F)=CC=C(C=2NC(=O)NC(=O)C=2)C=1CCOC1CCCCO1 YDQTWCVCCXQCGZ-UHFFFAOYSA-N 0.000 description 2
• AFWWKZCPPRPDQK-UHFFFAOYSA-N 6-chloropyridine-3-carbaldehyde Chemical compound ClC1=CC=C(C=O)C=N1 AFWWKZCPPRPDQK-UHFFFAOYSA-N 0.000 description 2
• AMKGKYQBASDDJB-UHFFFAOYSA-N 9$l^{2}-borabicyclo[3.3.1]nonane Chemical compound C1CCC2CCCC1[B]2 AMKGKYQBASDDJB-UHFFFAOYSA-N 0.000 description 2
• NUMDIKJSJXNHNQ-UHFFFAOYSA-N 9-fluoro-2-[[3-fluoro-4-[6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(F)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 NUMDIKJSJXNHNQ-UHFFFAOYSA-N 0.000 description 2
• LNOZZAHNOKWRDO-UHFFFAOYSA-N 9-fluoro-2-[[3-fluoro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(F)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 LNOZZAHNOKWRDO-UHFFFAOYSA-N 0.000 description 2
• AKUJAKRCPYMYIL-UHFFFAOYSA-N 9-fluoro-2-[[4-[2-(trifluoromethyl)pyrimidin-5-yl]oxyphenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(F)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1)=CC=C1OC1=CN=C(C(F)(F)F)N=C1 AKUJAKRCPYMYIL-UHFFFAOYSA-N 0.000 description 2
• CHTSSWKAUWCIGU-UHFFFAOYSA-N 9-fluoro-6,7-dihydropyrimido[6,1-a]isoquinoline-2,4-dione Chemical compound C12=CC=C(F)C=C2CCN2C1=CC(O)=NC2=O CHTSSWKAUWCIGU-UHFFFAOYSA-N 0.000 description 2
• APALWHCPXDAQOM-UHFFFAOYSA-N 9-methoxy-2-[2-[5-[3-(trifluoromethyl)phenoxy]pyridin-2-yl]ethoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(N=C1)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 APALWHCPXDAQOM-UHFFFAOYSA-N 0.000 description 2
• OGMQLSNSHQPRKO-UHFFFAOYSA-N 9-methoxy-2-[[5-[3-(trifluoromethyl)phenoxy]pyridin-2-yl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(N=C1)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 OGMQLSNSHQPRKO-UHFFFAOYSA-N 0.000 description 2
• GYBHYFYZRHZIDA-UHFFFAOYSA-N 9-methoxy-2-[[6-[3-(trifluoromethyl)phenoxy]pyridin-3-yl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=N1)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 GYBHYFYZRHZIDA-UHFFFAOYSA-N 0.000 description 2
• IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• 206010002383 Angina Pectoris Diseases 0.000 description 2
• XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 208000037260 Atherosclerotic Plaque Diseases 0.000 description 2
• WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 2
• 208000020084 Bone disease Diseases 0.000 description 2
• 206010065687 Bone loss Diseases 0.000 description 2
• 125000006374 C2-C10 alkenyl group Chemical group 0.000 description 2
• 125000005865 C2-C10alkynyl group Chemical group 0.000 description 2
• 0 COc(cc1)cc(CCN23)c1C2=CC(*CCc(cc1)cc(C#N)c1Oc1ncc(C(F)(F)F)cc1)=NC3=O Chemical compound COc(cc1)cc(CCN23)c1C2=CC(*CCc(cc1)cc(C#N)c1Oc1ncc(C(F)(F)F)cc1)=NC3=O 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
• 229920002261 Corn starch Polymers 0.000 description 2
• BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 2
• 208000032928 Dyslipidaemia Diseases 0.000 description 2
• QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
• AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 2
• 229910004373 HOAc Inorganic materials 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
• 201000002980 Hyperparathyroidism Diseases 0.000 description 2
• 206010020772 Hypertension Diseases 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• 208000017170 Lipid metabolism disease Diseases 0.000 description 2
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
• 102100037611 Lysophospholipase Human genes 0.000 description 2
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
• OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 2
• 208000001145 Metabolic Syndrome Diseases 0.000 description 2
• 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
• 229920000881 Modified starch Polymers 0.000 description 2
• MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
• WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
• GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 2
• HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 2
• LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Substances IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 2
• 208000036110 Neuroinflammatory disease Diseases 0.000 description 2
• 208000010191 Osteitis Deformans Diseases 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 208000027868 Paget disease Diseases 0.000 description 2
• URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 2
• 101150003085 Pdcl gene Proteins 0.000 description 2
• 239000007868 Raney catalyst Substances 0.000 description 2
• NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
• 229910000564 Raney nickel Inorganic materials 0.000 description 2
• XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 description 2
• YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
• DDBNTAFBODELND-UHFFFAOYSA-N S-[[3-cyano-4-[3-(trifluoromethyl)phenoxy]phenyl]methyl] ethanethioate Chemical compound N#CC1=CC(CSC(=O)C)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 DDBNTAFBODELND-UHFFFAOYSA-N 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
• WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• 208000006011 Stroke Diseases 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• VCZPIZMCFQZRBO-UHFFFAOYSA-N [2-(trifluoromethyl)-4-[3-(trifluoromethyl)phenoxy]phenyl]methanol Chemical compound C1=C(C(F)(F)F)C(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 VCZPIZMCFQZRBO-UHFFFAOYSA-N 0.000 description 2
• AAJAIHUXTLUWMK-UHFFFAOYSA-N [2-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]methanol Chemical compound C1=C(Cl)C(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 AAJAIHUXTLUWMK-UHFFFAOYSA-N 0.000 description 2
• ZZDRVSGBGWMLBO-UHFFFAOYSA-N [2-chloro-4-[4-chloro-3-(trifluoromethyl)phenoxy]phenyl]methanol Chemical compound C1=C(Cl)C(CO)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 ZZDRVSGBGWMLBO-UHFFFAOYSA-N 0.000 description 2
• WEVWYKYOFYXSMT-UHFFFAOYSA-N [2-chloro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]methanol Chemical compound C1=C(Cl)C(CO)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 WEVWYKYOFYXSMT-UHFFFAOYSA-N 0.000 description 2
• TWPXNEJHEGOPFY-UHFFFAOYSA-N [3-bromo-4-[3-(trifluoromethyl)phenoxy]phenyl]methanol Chemical compound BrC1=CC(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 TWPXNEJHEGOPFY-UHFFFAOYSA-N 0.000 description 2
• VPGJPIJZLXZBON-UHFFFAOYSA-N [3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]methanol Chemical compound ClC1=CC(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 VPGJPIJZLXZBON-UHFFFAOYSA-N 0.000 description 2
• QIQBJBKKJYZOGS-UHFFFAOYSA-N [3-fluoro-4-(6-methylpyridin-3-yl)oxyphenyl]methanol Chemical compound C1=NC(C)=CC=C1OC1=CC=C(CO)C=C1F QIQBJBKKJYZOGS-UHFFFAOYSA-N 0.000 description 2
• KFRJQOXIOLVYKL-UHFFFAOYSA-N [3-fluoro-4-[2-(trifluoromethyl)pyrimidin-5-yl]oxyphenyl]methanol Chemical compound FC1=CC(CO)=CC=C1OC1=CN=C(C(F)(F)F)N=C1 KFRJQOXIOLVYKL-UHFFFAOYSA-N 0.000 description 2
• IETUFLRJCSABGT-UHFFFAOYSA-N [3-fluoro-4-[3-(trifluoromethyl)phenoxy]phenyl]methanol Chemical compound FC1=CC(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 IETUFLRJCSABGT-UHFFFAOYSA-N 0.000 description 2
• GGEQJEMZBDACIS-UHFFFAOYSA-N [3-fluoro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]methanol Chemical compound FC1=CC(CO)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 GGEQJEMZBDACIS-UHFFFAOYSA-N 0.000 description 2
• SRAUERLBJNRURE-UHFFFAOYSA-N [3-methoxy-4-[3-(trifluoromethyl)phenoxy]phenyl]methanol Chemical compound COC1=CC(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 SRAUERLBJNRURE-UHFFFAOYSA-N 0.000 description 2
• BMBMIIIDUROWKI-UHFFFAOYSA-N [3-methyl-4-[3-(trifluoromethyl)phenoxy]phenyl]methanol Chemical compound CC1=CC(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 BMBMIIIDUROWKI-UHFFFAOYSA-N 0.000 description 2
• MARJOUQRFIOWAV-UHFFFAOYSA-N [4-(5-chloropyridin-2-yl)oxy-3-fluorophenyl]methanol Chemical compound FC1=CC(CO)=CC=C1OC1=CC=C(Cl)C=N1 MARJOUQRFIOWAV-UHFFFAOYSA-N 0.000 description 2
• JAELIMBHZGTLOX-UHFFFAOYSA-N [4-(5-chloropyridin-3-yl)oxyphenyl]methanamine Chemical compound C1=CC(CN)=CC=C1OC1=CN=CC(Cl)=C1 JAELIMBHZGTLOX-UHFFFAOYSA-N 0.000 description 2
• VMNWIYCQIOLLAZ-UHFFFAOYSA-N [4-[4-chloro-3-(trifluoromethyl)phenoxy]-2-(trifluoromethyl)phenyl]methanol Chemical compound C1=C(C(F)(F)F)C(CO)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 VMNWIYCQIOLLAZ-UHFFFAOYSA-N 0.000 description 2
• QYZQBEDWODSGRI-UHFFFAOYSA-N [5-[4-chloro-3-(trifluoromethyl)phenoxy]pyrimidin-2-yl]methanol Chemical compound C1=NC(CO)=NC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 QYZQBEDWODSGRI-UHFFFAOYSA-N 0.000 description 2
• VYFKCJZXQHPHAI-UHFFFAOYSA-N [5-[4-fluoro-3-(trifluoromethyl)phenoxy]pyridin-2-yl]methanol Chemical compound C1=NC(CO)=CC=C1OC1=CC=C(F)C(C(F)(F)F)=C1 VYFKCJZXQHPHAI-UHFFFAOYSA-N 0.000 description 2
• AOEZEKRXAVQUBJ-UHFFFAOYSA-N [5-chloro-6-[3-(trifluoromethyl)phenoxy]pyridin-3-yl]methanol Chemical compound ClC1=CC(CO)=CN=C1OC1=CC=CC(C(F)(F)F)=C1 AOEZEKRXAVQUBJ-UHFFFAOYSA-N 0.000 description 2
• MYQINQCUHLRXIC-UHFFFAOYSA-N [5-fluoro-6-(4-fluorophenoxy)pyridin-3-yl]methanol Chemical compound FC1=CC(CO)=CN=C1OC1=CC=C(F)C=C1 MYQINQCUHLRXIC-UHFFFAOYSA-N 0.000 description 2
• CYAFEUNJCHSFGQ-UHFFFAOYSA-N [5-fluoro-6-[3-(trifluoromethyl)phenoxy]pyridin-3-yl]methanol Chemical compound FC1=CC(CO)=CN=C1OC1=CC=CC(C(F)(F)F)=C1 CYAFEUNJCHSFGQ-UHFFFAOYSA-N 0.000 description 2
• LYIWXTPGUBKHRP-UHFFFAOYSA-N [5-fluoro-6-[4-fluoro-3-(trifluoromethyl)phenoxy]pyridin-3-yl]methanol Chemical compound FC1=CC(CO)=CN=C1OC1=CC=C(F)C(C(F)(F)F)=C1 LYIWXTPGUBKHRP-UHFFFAOYSA-N 0.000 description 2
• CFTZSCALYLBWKC-UHFFFAOYSA-N [6-[3-(trifluoromethyl)phenoxy]pyridin-3-yl]methanol Chemical compound N1=CC(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 CFTZSCALYLBWKC-UHFFFAOYSA-N 0.000 description 2
• OEZAERBJQAIMAW-UHFFFAOYSA-N [6-[4-chloro-3-(trifluoromethyl)phenoxy]-5-fluoropyridin-3-yl]methanol Chemical compound FC1=CC(CO)=CN=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 OEZAERBJQAIMAW-UHFFFAOYSA-N 0.000 description 2
• 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• 235000010443 alginic acid Nutrition 0.000 description 2
• 239000000783 alginic acid Substances 0.000 description 2
• 229920000615 alginic acid Polymers 0.000 description 2
• 229960001126 alginic acid Drugs 0.000 description 2
• 150000004781 alginic acids Chemical class 0.000 description 2
• 229910052782 aluminium Inorganic materials 0.000 description 2
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
• 150000001413 amino acids Chemical class 0.000 description 2
• 108010064539 amyloid beta-protein (1-42) Proteins 0.000 description 2
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 2
• 238000004458 analytical method Methods 0.000 description 2
• 239000003472 antidiabetic agent Substances 0.000 description 2
• 229940125708 antidiabetic agent Drugs 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 2
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
• 235000019445 benzyl alcohol Nutrition 0.000 description 2
• 229960004217 benzyl alcohol Drugs 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 210000004155 blood-retinal barrier Anatomy 0.000 description 2
• 230000004378 blood-retinal barrier Effects 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 238000009835 boiling Methods 0.000 description 2
• 210000001185 bone marrow Anatomy 0.000 description 2
• UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
• 210000005013 brain tissue Anatomy 0.000 description 2
• 229910052794 bromium Inorganic materials 0.000 description 2
• 125000001246 bromo group Chemical group Br* 0.000 description 2
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 229910052791 calcium Inorganic materials 0.000 description 2
• 239000001110 calcium chloride Substances 0.000 description 2
• 229910001628 calcium chloride Inorganic materials 0.000 description 2
• OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
• 239000003054 catalyst Substances 0.000 description 2
• 230000003197 catalytic effect Effects 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 235000010980 cellulose Nutrition 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 206010008118 cerebral infarction Diseases 0.000 description 2
• 125000001309 chloro group Chemical group Cl* 0.000 description 2
• 229940125797 compound 12 Drugs 0.000 description 2
• 229940126543 compound 14 Drugs 0.000 description 2
• 229940125782 compound 2 Drugs 0.000 description 2
• 239000000470 constituent Substances 0.000 description 2
• DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 2
• 239000008120 corn starch Substances 0.000 description 2
• 208000029078 coronary artery disease Diseases 0.000 description 2
• 125000004093 cyano group Chemical group *C#N 0.000 description 2
• PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 238000001035 drying Methods 0.000 description 2
• 230000004064 dysfunction Effects 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• 229940011871 estrogen Drugs 0.000 description 2
• 239000000262 estrogen Substances 0.000 description 2
• CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
• 239000012065 filter cake Substances 0.000 description 2
• 238000001914 filtration Methods 0.000 description 2
• 239000000796 flavoring agent Substances 0.000 description 2
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
• 239000006260 foam Substances 0.000 description 2
• 238000009472 formulation Methods 0.000 description 2
• 235000021588 free fatty acids Nutrition 0.000 description 2
• 125000001188 haloalkyl group Chemical group 0.000 description 2
• 229910052736 halogen Inorganic materials 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 239000001257 hydrogen Substances 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
• 238000011065 in-situ storage Methods 0.000 description 2
• 239000003999 initiator Substances 0.000 description 2
• 230000003902 lesion Effects 0.000 description 2
• 229910052744 lithium Inorganic materials 0.000 description 2
• 239000011777 magnesium Substances 0.000 description 2
• 229910052749 magnesium Inorganic materials 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
• 208000027202 mammary Paget disease Diseases 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
• SJFNDMHZXCUXSA-UHFFFAOYSA-M methoxymethyl(triphenyl)phosphanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(COC)C1=CC=CC=C1 SJFNDMHZXCUXSA-UHFFFAOYSA-M 0.000 description 2
• NNUPSPHVCPBCJI-UHFFFAOYSA-N methyl 3-cyano-4-[5-(trifluoromethyl)pyridin-2-yl]oxybenzoate Chemical compound N#CC1=CC(C(=O)OC)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 NNUPSPHVCPBCJI-UHFFFAOYSA-N 0.000 description 2
• QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
• NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 2
• 229940016286 microcrystalline cellulose Drugs 0.000 description 2
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
• 239000008108 microcrystalline cellulose Substances 0.000 description 2
• FLOPYZXYIGHBJL-UHFFFAOYSA-N n-[2-(3-methoxyphenyl)ethyl]acetamide Chemical compound COC1=CC=CC(CCNC(C)=O)=C1 FLOPYZXYIGHBJL-UHFFFAOYSA-N 0.000 description 2
• 230000003959 neuroinflammation Effects 0.000 description 2
• 230000007658 neurological function Effects 0.000 description 2
• LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
• ZHCAAFJSYLFLPX-UHFFFAOYSA-N nitrocyclohexatriene Chemical group [O-][N+](=O)C1=CC=C=C[CH]1 ZHCAAFJSYLFLPX-UHFFFAOYSA-N 0.000 description 2
• 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
• 230000001575 pathological effect Effects 0.000 description 2
• 230000007170 pathology Effects 0.000 description 2
• 230000010412 perfusion Effects 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
• HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 description 2
• GKKCIDNWFBPDBW-UHFFFAOYSA-M potassium cyanate Chemical compound [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 description 2
• 229920001592 potato starch Polymers 0.000 description 2
• 239000002244 precipitate Substances 0.000 description 2
• 230000002265 prevention Effects 0.000 description 2
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
• 238000010791 quenching Methods 0.000 description 2
• 230000000171 quenching effect Effects 0.000 description 2
• 238000001953 recrystallisation Methods 0.000 description 2
• 208000004644 retinal vein occlusion Diseases 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
• 229910001961 silver nitrate Inorganic materials 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 239000001632 sodium acetate Substances 0.000 description 2
• 235000017281 sodium acetate Nutrition 0.000 description 2
• QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 2
• 235000010288 sodium nitrite Nutrition 0.000 description 2
• 239000012321 sodium triacetoxyborohydride Substances 0.000 description 2
• 229940032147 starch Drugs 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 229960001685 tacrine Drugs 0.000 description 2
• YLJREFDVOIBQDA-UHFFFAOYSA-N tacrine Chemical compound C1=CC=C2C(N)=C(CCCC3)C3=NC2=C1 YLJREFDVOIBQDA-UHFFFAOYSA-N 0.000 description 2
• 125000004001 thioalkyl group Chemical group 0.000 description 2
• 150000003573 thiols Chemical class 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 230000002792 vascular Effects 0.000 description 2
• 239000003643 water by type Substances 0.000 description 2
• 230000029663 wound healing Effects 0.000 description 2
• 239000011701 zinc Substances 0.000 description 2
• AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
• UTAHHFAWQFQUBG-UHFFFAOYSA-N (3-fluoro-4-pyrimidin-5-yloxyphenyl)methanol Chemical compound FC1=CC(CO)=CC=C1OC1=CN=CN=C1 UTAHHFAWQFQUBG-UHFFFAOYSA-N 0.000 description 1
• ZGGHKIMDNBDHJB-NRFPMOEYSA-M (3R,5S)-fluvastatin sodium Chemical compound [Na+].C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 ZGGHKIMDNBDHJB-NRFPMOEYSA-M 0.000 description 1
• QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• GFVNHIWEWBQRAX-UHFFFAOYSA-N (6-pyridin-4-yloxypyridin-3-yl)methanol Chemical compound N1=CC(CO)=CC=C1OC1=CC=NC=C1 GFVNHIWEWBQRAX-UHFFFAOYSA-N 0.000 description 1
• 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
• SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical compound CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 description 1
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
• SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
• WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
• UYBWIEGTWASWSR-UHFFFAOYSA-N 1,3-diaminopropan-2-ol Chemical compound NCC(O)CN UYBWIEGTWASWSR-UHFFFAOYSA-N 0.000 description 1
• ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
• YGIABALXNBVHBX-UHFFFAOYSA-N 1-[4-[7-(diethylamino)-4-methyl-2-oxochromen-3-yl]phenyl]pyrrole-2,5-dione Chemical compound O=C1OC2=CC(N(CC)CC)=CC=C2C(C)=C1C(C=C1)=CC=C1N1C(=O)C=CC1=O YGIABALXNBVHBX-UHFFFAOYSA-N 0.000 description 1
• UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
• BSOWNBFHYIDBEK-UHFFFAOYSA-N 1-bromo-4-fluoro-2-(2-methoxyethenyl)benzene Chemical compound COC=CC1=CC(F)=CC=C1Br BSOWNBFHYIDBEK-UHFFFAOYSA-N 0.000 description 1
• QYUMGNBFACDGIT-UHFFFAOYSA-N 1-chloro-5-(dibromomethyl)-3-fluoro-2h-pyridine Chemical compound FC1=CC(C(Br)Br)=CN(Cl)C1 QYUMGNBFACDGIT-UHFFFAOYSA-N 0.000 description 1
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
• ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
• XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
• 238000005160 1H NMR spectroscopy Methods 0.000 description 1
• HCSBTDBGTNZOAB-UHFFFAOYSA-N 2,3-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=CC([N+]([O-])=O)=C1[N+]([O-])=O HCSBTDBGTNZOAB-UHFFFAOYSA-N 0.000 description 1
• NVWVWEWVLBKPSM-UHFFFAOYSA-N 2,4-difluorophenol Chemical compound OC1=CC=C(F)C=C1F NVWVWEWVLBKPSM-UHFFFAOYSA-N 0.000 description 1
• JYWKEVKEKOTYEX-UHFFFAOYSA-N 2,6-dibromo-4-chloroiminocyclohexa-2,5-dien-1-one Chemical compound ClN=C1C=C(Br)C(=O)C(Br)=C1 JYWKEVKEKOTYEX-UHFFFAOYSA-N 0.000 description 1
• YVBHKXLJVFYDNC-UHFFFAOYSA-N 2-(2-bromo-5-fluorophenoxy)oxane Chemical compound FC1=CC=C(Br)C(OC2OCCCC2)=C1 YVBHKXLJVFYDNC-UHFFFAOYSA-N 0.000 description 1
• CSZAWKYBHOEQQD-UHFFFAOYSA-N 2-(2-bromo-5-fluorophenyl)acetaldehyde Chemical compound FC1=CC=C(Br)C(CC=O)=C1 CSZAWKYBHOEQQD-UHFFFAOYSA-N 0.000 description 1
• ADLOWZRDUHSVRU-UHFFFAOYSA-N 2-(2-bromophenyl)ethanol Chemical compound OCCC1=CC=CC=C1Br ADLOWZRDUHSVRU-UHFFFAOYSA-N 0.000 description 1
• VJHIXSFFDGQAMJ-UHFFFAOYSA-N 2-(5-chloropyridin-2-yl)oxy-5-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=C(Cl)C=N1 VJHIXSFFDGQAMJ-UHFFFAOYSA-N 0.000 description 1
• ZJSZLKAHAAGWKK-UHFFFAOYSA-N 2-(5-chloropyridin-3-yl)oxy-5-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CN=CC(Cl)=C1 ZJSZLKAHAAGWKK-UHFFFAOYSA-N 0.000 description 1
• ZYFYGULZXUSJAF-UHFFFAOYSA-N 2-(5-chloropyridin-3-yl)oxy-5-[[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)-methylamino]methyl]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1N(C)CC(C=C1C#N)=CC=C1OC1=CN=CC(Cl)=C1 ZYFYGULZXUSJAF-UHFFFAOYSA-N 0.000 description 1
• SDFNMIBRTIBKSQ-UHFFFAOYSA-N 2-(5-chloropyridin-3-yl)oxy-5-[[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)amino]methyl]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1NCC(C=C1C#N)=CC=C1OC1=CN=CC(Cl)=C1 SDFNMIBRTIBKSQ-UHFFFAOYSA-N 0.000 description 1
• FOKQITBJYRPCTE-UHFFFAOYSA-N 2-(hydroxymethyl)-5-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound C1=C(C#N)C(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 FOKQITBJYRPCTE-UHFFFAOYSA-N 0.000 description 1
• OPIVCIYVTJDTNN-UHFFFAOYSA-N 2-(hydroxymethyl)-9-methoxy-6,7-dihydrobenzo[a]quinolizin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN1C2=CC(CO)=CC1=O OPIVCIYVTJDTNN-UHFFFAOYSA-N 0.000 description 1
• BQDJLAWUTBCDHK-UHFFFAOYSA-N 2-(trifluoromethyl)pyrimidine Chemical compound FC(F)(F)C1=NC=CC=N1 BQDJLAWUTBCDHK-UHFFFAOYSA-N 0.000 description 1
• JMXOZSYVFVGEFU-UHFFFAOYSA-N 2-[(3-fluoro-4-pyrimidin-5-yloxyphenyl)methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CN=CN=C1 JMXOZSYVFVGEFU-UHFFFAOYSA-N 0.000 description 1
• AMHYGUNGGGEHDU-UHFFFAOYSA-N 2-[2-(2-bromo-5-fluorophenyl)ethoxy]oxane Chemical compound FC1=CC=C(Br)C(CCOC2OCCCC2)=C1 AMHYGUNGGGEHDU-UHFFFAOYSA-N 0.000 description 1
• ZBRNWBHYYQYKAL-UHFFFAOYSA-N 2-[2-[4-[4-chloro-3-(trifluoromethyl)phenoxy]phenyl]ethoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(C=C1)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 ZBRNWBHYYQYKAL-UHFFFAOYSA-N 0.000 description 1
• GYCYDRXCWYLFNT-UHFFFAOYSA-N 2-[2-[5-[4-chloro-3-(trifluoromethyl)phenoxy]pyridin-2-yl]ethoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(N=C1)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 GYCYDRXCWYLFNT-UHFFFAOYSA-N 0.000 description 1
• AKLIGQUNVYILCU-UHFFFAOYSA-N 2-[2-[5-[4-fluoro-3-(trifluoromethyl)phenoxy]pyridin-2-yl]ethoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(N=C1)=CC=C1OC1=CC=C(F)C(C(F)(F)F)=C1 AKLIGQUNVYILCU-UHFFFAOYSA-N 0.000 description 1
• YKBYNZVETDFXLY-UHFFFAOYSA-N 2-[2-[6-(2,4-difluorophenoxy)pyridin-3-yl]ethoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(C=N1)=CC=C1OC1=CC=C(F)C=C1F YKBYNZVETDFXLY-UHFFFAOYSA-N 0.000 description 1
• NIQQCLGCSYFVJP-UHFFFAOYSA-N 2-[2-[6-[4-chloro-3-(trifluoromethyl)phenoxy]pyridin-3-yl]ethoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(C=N1)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 NIQQCLGCSYFVJP-UHFFFAOYSA-N 0.000 description 1
• GEXFILXCAGSDGA-UHFFFAOYSA-N 2-[3-chloro-4-(trifluoromethyl)phenoxy]-5-[[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)-methylamino]methyl]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1N(C)CC(C=C1C#N)=CC=C1OC1=CC=C(C(F)(F)F)C(Cl)=C1 GEXFILXCAGSDGA-UHFFFAOYSA-N 0.000 description 1
• HRPYEIIFRQMTAF-UHFFFAOYSA-N 2-[3-chloro-4-(trifluoromethyl)phenoxy]-5-formylbenzonitrile Chemical compound C1=C(Cl)C(C(F)(F)F)=CC=C1OC1=CC=C(C=O)C=C1C#N HRPYEIIFRQMTAF-UHFFFAOYSA-N 0.000 description 1
• DSZAZQBMKVHDES-UHFFFAOYSA-N 2-[4-chloro-3-(trifluoromethyl)phenoxy]-5-(2-methoxyethenyl)pyridine Chemical compound N1=CC(C=COC)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 DSZAZQBMKVHDES-UHFFFAOYSA-N 0.000 description 1
• HMNDFLUCQMTHOA-UHFFFAOYSA-N 2-[4-chloro-3-(trifluoromethyl)phenoxy]-5-[(4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]benzonitrile Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C(=CC(COC3=NC(=O)N4CCC5=CC=CC=C5C4=C3)=CC=2)C#N)=C1 HMNDFLUCQMTHOA-UHFFFAOYSA-N 0.000 description 1
• TXLCZKAUYWTCTJ-UHFFFAOYSA-N 2-[4-chloro-3-(trifluoromethyl)phenoxy]-5-[(9-fluoro-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]benzonitrile Chemical compound C=1C(F)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 TXLCZKAUYWTCTJ-UHFFFAOYSA-N 0.000 description 1
• DSZAZQBMKVHDES-VOTSOKGWSA-N 2-[4-chloro-3-(trifluoromethyl)phenoxy]-5-[(e)-2-methoxyethenyl]pyridine Chemical compound N1=CC(/C=C/OC)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 DSZAZQBMKVHDES-VOTSOKGWSA-N 0.000 description 1
• CUJCPHVMFQVRRF-UHFFFAOYSA-N 2-[4-chloro-3-(trifluoromethyl)phenoxy]-5-[[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)amino]methyl]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1NCC(C=C1C#N)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 CUJCPHVMFQVRRF-UHFFFAOYSA-N 0.000 description 1
• OEPHSWFIOSSYMC-UHFFFAOYSA-N 2-[4-chloro-3-(trifluoromethyl)phenoxy]-5-hydroxybenzonitrile Chemical compound N#CC1=CC(O)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 OEPHSWFIOSSYMC-UHFFFAOYSA-N 0.000 description 1
• KFUMPMCZCVFNAM-UHFFFAOYSA-N 2-[4-fluoro-3-(trifluoromethyl)phenoxy]-5-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=C(F)C(C(F)(F)F)=C1 KFUMPMCZCVFNAM-UHFFFAOYSA-N 0.000 description 1
• SPHUIKAUIGKZDX-UHFFFAOYSA-N 2-[6-[4-chloro-3-(trifluoromethyl)phenoxy]pyridin-3-yl]acetaldehyde Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2N=CC(CC=O)=CC=2)=C1 SPHUIKAUIGKZDX-UHFFFAOYSA-N 0.000 description 1
• FEDLWVMDCYDBET-UHFFFAOYSA-N 2-[[2-chloro-4-[4-chloro-3-(trifluoromethyl)phenoxy]phenyl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C(=C1)Cl)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 FEDLWVMDCYDBET-UHFFFAOYSA-N 0.000 description 1
• IGNMSQFKQOEGQF-UHFFFAOYSA-N 2-[[3,5-difluoro-4-[3-(trifluoromethyl)phenoxy]phenyl]methylamino]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1NCC(C=C1F)=CC(F)=C1OC1=CC=CC(C(F)(F)F)=C1 IGNMSQFKQOEGQF-UHFFFAOYSA-N 0.000 description 1
• JMDBRIWHNCZAMQ-UHFFFAOYSA-N 2-[[3,5-difluoro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound FC1=CC(COC2=NC(=O)N3CCC4=CC=CC=C4C3=C2)=CC(F)=C1OC1=CC=C(C(F)(F)F)N=C1 JMDBRIWHNCZAMQ-UHFFFAOYSA-N 0.000 description 1
• QFOLKTAFNHCHNB-UHFFFAOYSA-N 2-[[3-(5-chloropyridin-2-yl)oxy-4-fluorophenyl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=1)=CC=C(F)C=1OC1=CC=C(Cl)C=N1 QFOLKTAFNHCHNB-UHFFFAOYSA-N 0.000 description 1
• IZPJHQBNVRVVPN-UHFFFAOYSA-N 2-[[3-bromo-4-[3-(trifluoromethyl)phenoxy]phenyl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1Br)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 IZPJHQBNVRVVPN-UHFFFAOYSA-N 0.000 description 1
• AZRGWDSMWFYRCW-UHFFFAOYSA-N 2-[[3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1Cl)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 AZRGWDSMWFYRCW-UHFFFAOYSA-N 0.000 description 1
• FOSABYZRNROPOL-UHFFFAOYSA-N 2-[[3-chloro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1Cl)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 FOSABYZRNROPOL-UHFFFAOYSA-N 0.000 description 1
• OBPZBJXKSIKOIQ-UHFFFAOYSA-N 2-[[3-fluoro-4-[2-(trifluoromethyl)pyrimidin-5-yl]oxyphenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound FC1=CC(COC2=NC(=O)N3CCC4=CC=CC=C4C3=C2)=CC=C1OC1=CN=C(C(F)(F)F)N=C1 OBPZBJXKSIKOIQ-UHFFFAOYSA-N 0.000 description 1
• LRMBESBGNVOFNV-UHFFFAOYSA-N 2-[[3-fluoro-4-[2-(trifluoromethyl)pyrimidin-5-yl]oxyphenyl]methoxy]-9-methyl-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(C)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CN=C(C(F)(F)F)N=C1 LRMBESBGNVOFNV-UHFFFAOYSA-N 0.000 description 1
• QIZHEUSTTXDUME-UHFFFAOYSA-N 2-[[3-fluoro-4-[3-(trifluoromethyl)phenoxy]phenyl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 QIZHEUSTTXDUME-UHFFFAOYSA-N 0.000 description 1
• SUQYUPNHIZTXNG-UHFFFAOYSA-N 2-[[3-fluoro-4-[3-(trifluoromethyl)phenoxy]phenyl]methylamino]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1NCC(C=C1F)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 SUQYUPNHIZTXNG-UHFFFAOYSA-N 0.000 description 1
• OBEOXHPWWHTGTG-UHFFFAOYSA-N 2-[[3-fluoro-4-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound FC1=CC(COC2=NC(=O)N3CCC4=CC=CC=C4C3=C2)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 OBEOXHPWWHTGTG-UHFFFAOYSA-N 0.000 description 1
• RIKYWZPUOUHDIR-UHFFFAOYSA-N 2-[[3-fluoro-4-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 RIKYWZPUOUHDIR-UHFFFAOYSA-N 0.000 description 1
• HIFIUZZZDWXZOX-UHFFFAOYSA-N 2-[[3-fluoro-4-[6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 HIFIUZZZDWXZOX-UHFFFAOYSA-N 0.000 description 1
• REWORKHVBPBGFW-UHFFFAOYSA-N 2-[[3-fluoro-4-[6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methoxy]-9-methyl-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(C)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 REWORKHVBPBGFW-UHFFFAOYSA-N 0.000 description 1
• TYDJJSWUSRHPDB-UHFFFAOYSA-N 2-[[3-fluoro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound FC1=CC(COC2=NC(=O)N3CCC4=CC=CC=C4C3=C2)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 TYDJJSWUSRHPDB-UHFFFAOYSA-N 0.000 description 1
• IDOOVIPMIUHCER-UHFFFAOYSA-N 2-[[3-fluoro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 IDOOVIPMIUHCER-UHFFFAOYSA-N 0.000 description 1
• HKCPFODMFPDEBF-UHFFFAOYSA-N 2-[[3-fluoro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]methoxy]-9-methyl-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(C)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 HKCPFODMFPDEBF-UHFFFAOYSA-N 0.000 description 1
• JZHSMQCFKIYVPR-UHFFFAOYSA-N 2-[[4-(5-chloropyridin-2-yl)oxy-3-fluorophenyl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CC=C(Cl)C=N1 JZHSMQCFKIYVPR-UHFFFAOYSA-N 0.000 description 1
• VCDVLPPCWVVEPV-UHFFFAOYSA-N 2-[[4-(5-chloropyridin-3-yl)oxyphenyl]methylamino]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1NCC(C=C1)=CC=C1OC1=CN=CC(Cl)=C1 VCDVLPPCWVVEPV-UHFFFAOYSA-N 0.000 description 1
• VGFOPQJYVOSLPB-UHFFFAOYSA-N 2-[[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2-(trifluoromethyl)phenyl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C(=C1)C(F)(F)F)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 VGFOPQJYVOSLPB-UHFFFAOYSA-N 0.000 description 1
• TUNZAGAFQUNMQL-UHFFFAOYSA-N 2-[[5-[4-chloro-3-(trifluoromethyl)phenoxy]pyridin-2-yl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2C=NC(COC3=NC(=O)N4CCC5=CC=CC=C5C4=C3)=CC=2)=C1 TUNZAGAFQUNMQL-UHFFFAOYSA-N 0.000 description 1
• RAOIBTWIOVIXPC-UHFFFAOYSA-N 2-[[5-[4-chloro-3-(trifluoromethyl)phenoxy]pyridin-2-yl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(N=C1)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 RAOIBTWIOVIXPC-UHFFFAOYSA-N 0.000 description 1
• WRUDXKNGHZIDDB-UHFFFAOYSA-N 2-[[5-[4-chloro-3-(trifluoromethyl)phenoxy]pyridin-2-yl]methoxy]-9-methyl-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(C)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(N=C1)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 WRUDXKNGHZIDDB-UHFFFAOYSA-N 0.000 description 1
• DYHXHPZPPGMONL-UHFFFAOYSA-N 2-[[5-[4-chloro-3-(trifluoromethyl)phenoxy]pyrimidin-2-yl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(N=C1)=NC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 DYHXHPZPPGMONL-UHFFFAOYSA-N 0.000 description 1
• PAGCYGVBZCSNPW-UHFFFAOYSA-N 2-[[5-[4-fluoro-3-(trifluoromethyl)phenoxy]pyridin-2-yl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C1=C(C(F)(F)F)C(F)=CC=C1OC(C=N1)=CC=C1COC1=NC(=O)N2CCC3=CC=CC=C3C2=C1 PAGCYGVBZCSNPW-UHFFFAOYSA-N 0.000 description 1
• CRSBLHCXOUJXTD-UHFFFAOYSA-N 2-[[5-[4-fluoro-3-(trifluoromethyl)phenoxy]pyridin-2-yl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(N=C1)=CC=C1OC1=CC=C(F)C(C(F)(F)F)=C1 CRSBLHCXOUJXTD-UHFFFAOYSA-N 0.000 description 1
• FNVIEGXOUXECOO-UHFFFAOYSA-N 2-[[5-chloro-6-[3-(trifluoromethyl)phenoxy]pyridin-3-yl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1Cl)=CN=C1OC1=CC=CC(C(F)(F)F)=C1 FNVIEGXOUXECOO-UHFFFAOYSA-N 0.000 description 1
• RGVMGIFKVHGFNT-UHFFFAOYSA-N 2-[[5-fluoro-6-(4-fluorophenoxy)pyridin-3-yl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CN=C1OC1=CC=C(F)C=C1 RGVMGIFKVHGFNT-UHFFFAOYSA-N 0.000 description 1
• DWBJQAOYINXRDN-UHFFFAOYSA-N 2-[[5-fluoro-6-[3-(trifluoromethyl)phenoxy]pyridin-3-yl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CN=C1OC1=CC=CC(C(F)(F)F)=C1 DWBJQAOYINXRDN-UHFFFAOYSA-N 0.000 description 1
• GJUARTWDZUICOS-UHFFFAOYSA-N 2-[[5-fluoro-6-[4-fluoro-3-(trifluoromethyl)phenoxy]pyridin-3-yl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CN=C1OC1=CC=C(F)C(C(F)(F)F)=C1 GJUARTWDZUICOS-UHFFFAOYSA-N 0.000 description 1
• FGWGMWMHTJQWIL-UHFFFAOYSA-N 2-[[6-[4-chloro-3-(trifluoromethyl)phenoxy]pyridin-3-yl]methoxy]-9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=N1)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 FGWGMWMHTJQWIL-UHFFFAOYSA-N 0.000 description 1
• MLXDUYUQINCFFV-UHFFFAOYSA-N 2-acetyloxyacetic acid Chemical compound CC(=O)OCC(O)=O MLXDUYUQINCFFV-UHFFFAOYSA-N 0.000 description 1
• CJUCIKJLMFVWIS-UHFFFAOYSA-N 2-bromo-5-fluorobenzaldehyde Chemical compound FC1=CC=C(Br)C(C=O)=C1 CJUCIKJLMFVWIS-UHFFFAOYSA-N 0.000 description 1
• XZJURWKNRAGMCG-UHFFFAOYSA-N 2-chloro-3-fluoro-5-methylpyridine Chemical compound CC1=CN=C(Cl)C(F)=C1 XZJURWKNRAGMCG-UHFFFAOYSA-N 0.000 description 1
• HVYDKQYZNXUFLW-UHFFFAOYSA-N 2-chloro-5-(dibromomethyl)-3-fluoropyridine Chemical compound FC1=CC(C(Br)Br)=CN=C1Cl HVYDKQYZNXUFLW-UHFFFAOYSA-N 0.000 description 1
• NPXDBRKXSAFIMK-UHFFFAOYSA-N 2-ethenyl-4-fluoro-5-(4-methylphenoxy)pyridine Chemical compound C1=CC(C)=CC=C1OC1=CN=C(C=C)C=C1F NPXDBRKXSAFIMK-UHFFFAOYSA-N 0.000 description 1
• CHZCERSEMVWNHL-UHFFFAOYSA-N 2-hydroxybenzonitrile Chemical compound OC1=CC=CC=C1C#N CHZCERSEMVWNHL-UHFFFAOYSA-N 0.000 description 1
• 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• XFKYJMGXZXJYBS-UHFFFAOYSA-N 3,4,5-trifluorobenzonitrile Chemical compound FC1=CC(C#N)=CC(F)=C1F XFKYJMGXZXJYBS-UHFFFAOYSA-N 0.000 description 1
• BTBFCBQZFMQBNT-UHFFFAOYSA-N 3,4-difluorobenzonitrile Chemical compound FC1=CC=C(C#N)C=C1F BTBFCBQZFMQBNT-UHFFFAOYSA-N 0.000 description 1
• JTZSFNHHVULOGJ-UHFFFAOYSA-N 3-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=CN=C1 JTZSFNHHVULOGJ-UHFFFAOYSA-N 0.000 description 1
• FAHZIKXYYRGSHF-UHFFFAOYSA-N 3-bromo-4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1Br FAHZIKXYYRGSHF-UHFFFAOYSA-N 0.000 description 1
• OMRCXTBFBBWTDL-UHFFFAOYSA-N 3-chloro-5-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CN=CC(Cl)=C1 OMRCXTBFBBWTDL-UHFFFAOYSA-N 0.000 description 1
• RSEOFGXKKBWGEN-UHFFFAOYSA-N 3-cyano-4-[3-(trifluoromethyl)phenoxy]benzoic acid Chemical compound N#CC1=CC(C(=O)O)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 RSEOFGXKKBWGEN-UHFFFAOYSA-N 0.000 description 1
• MJDZWYNXMPFSJE-UHFFFAOYSA-N 3-fluoro-5-formylbenzonitrile Chemical compound FC1=CC(C=O)=CC(C#N)=C1 MJDZWYNXMPFSJE-UHFFFAOYSA-N 0.000 description 1
• OSZPQAVSDJCMHN-UHFFFAOYSA-N 4,4,5,5-tetramethyl-2-[2-[2-(oxan-2-yloxy)ethyl]phenyl]-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=CC=C1CCOC1OCCCC1 OSZPQAVSDJCMHN-UHFFFAOYSA-N 0.000 description 1
• SHPJKELQVILRKU-UHFFFAOYSA-N 4-(hydroxymethyl)-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound OCC1=CC=C(C#N)C(OC=2C=C(C=CC=2)C(F)(F)F)=C1 SHPJKELQVILRKU-UHFFFAOYSA-N 0.000 description 1
• QTYQENVXAKFGMY-UHFFFAOYSA-N 4-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=1)=CC=C(C#N)C=1OC1=CC=CC(C(F)(F)F)=C1 QTYQENVXAKFGMY-UHFFFAOYSA-N 0.000 description 1
• XIHQIBORDMHGPU-UHFFFAOYSA-N 4-[2-(trifluoromethyl)pyrimidin-5-yl]oxybenzaldehyde Chemical compound C1=NC(C(F)(F)F)=NC=C1OC1=CC=C(C=O)C=C1 XIHQIBORDMHGPU-UHFFFAOYSA-N 0.000 description 1
• HVBSAKJJOYLTQU-UHFFFAOYSA-M 4-aminobenzenesulfonate Chemical compound NC1=CC=C(S([O-])(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-M 0.000 description 1
• WUBBRNOQWQTFEX-UHFFFAOYSA-M 4-aminosalicylate(1-) Chemical compound NC1=CC=C(C([O-])=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-M 0.000 description 1
• JVVRCYWZTJLJSG-UHFFFAOYSA-N 4-dimethylaminophenol Chemical compound CN(C)C1=CC=C(O)C=C1 JVVRCYWZTJLJSG-UHFFFAOYSA-N 0.000 description 1
• 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
• BIUDHHGROGJSHN-UHFFFAOYSA-N 4-fluoro-3-(trifluoromethyl)benzaldehyde Chemical compound FC1=CC=C(C=O)C=C1C(F)(F)F BIUDHHGROGJSHN-UHFFFAOYSA-N 0.000 description 1
• NALVGTOMKSKFFV-UHFFFAOYSA-N 4-fluoro-3-methoxybenzaldehyde Chemical compound COC1=CC(C=O)=CC=C1F NALVGTOMKSKFFV-UHFFFAOYSA-N 0.000 description 1
• NRFKZFFVTGGEQF-UHFFFAOYSA-N 4-fluoro-3-methylbenzaldehyde Chemical compound CC1=CC(C=O)=CC=C1F NRFKZFFVTGGEQF-UHFFFAOYSA-N 0.000 description 1
• GYLWJSOFHBYFMQ-UHFFFAOYSA-N 4-fluoropyridine-3-carbaldehyde Chemical compound FC1=CC=NC=C1C=O GYLWJSOFHBYFMQ-UHFFFAOYSA-N 0.000 description 1
• GCNTZFIIOFTKIY-UHFFFAOYSA-N 4-hydroxypyridine Chemical compound OC1=CC=NC=C1 GCNTZFIIOFTKIY-UHFFFAOYSA-N 0.000 description 1
• LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 description 1
• JHFNZQWZJQJDRY-UHFFFAOYSA-N 5-(2-hydroxyethyl)-2-[6-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound N#CC1=CC(CCO)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 JHFNZQWZJQJDRY-UHFFFAOYSA-N 0.000 description 1
• LFYQHNQUKDKDQN-UHFFFAOYSA-N 5-(2-methoxyethenyl)-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound N#CC1=CC(C=COC)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 LFYQHNQUKDKDQN-UHFFFAOYSA-N 0.000 description 1
• LEQAEUBCYVTUAF-UHFFFAOYSA-N 5-(4-ethenyl-2-fluorophenoxy)-2-methylpyridine Chemical compound C1=NC(C)=CC=C1OC1=CC=C(C=C)C=C1F LEQAEUBCYVTUAF-UHFFFAOYSA-N 0.000 description 1
• LKELLHAYDNRSHJ-UHFFFAOYSA-N 5-(aminomethyl)-2-[4-chloro-3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound N#CC1=CC(CN)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 LKELLHAYDNRSHJ-UHFFFAOYSA-N 0.000 description 1
• NFPDEUDAWOZMPC-UHFFFAOYSA-N 5-(bromomethyl)-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(CBr)=CC=2)C#N)=C1 NFPDEUDAWOZMPC-UHFFFAOYSA-N 0.000 description 1
• NKOHRVBBQISBSB-UHFFFAOYSA-N 5-[(4-hydroxyphenyl)methyl]-1,3-thiazolidine-2,4-dione Chemical class C1=CC(O)=CC=C1CC1C(=O)NC(=O)S1 NKOHRVBBQISBSB-UHFFFAOYSA-N 0.000 description 1
• BCELSSMJNQHATK-UHFFFAOYSA-N 5-[(4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(COC3=NC(=O)N4CCC5=CC=CC=C5C4=C3)=CC=2)C#N)=C1 BCELSSMJNQHATK-UHFFFAOYSA-N 0.000 description 1
• FGKDCLBJSBBMEJ-UHFFFAOYSA-N 5-[(9-chloro-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(COC3=NC(=O)N4CCC5=CC(Cl)=CC=C5C4=C3)=CC=2)C#N)=C1 FGKDCLBJSBBMEJ-UHFFFAOYSA-N 0.000 description 1
• BUJXBKYMAFSYFJ-UHFFFAOYSA-N 5-[(9-chloro-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[6-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound FC(F)(F)C1=CC=CC(OC=2C(=CC(COC3=NC(=O)N4CCC5=CC(Cl)=CC=C5C4=C3)=CC=2)C#N)=N1 BUJXBKYMAFSYFJ-UHFFFAOYSA-N 0.000 description 1
• RQRDNZUUEJHCPI-UHFFFAOYSA-N 5-[(9-chloro-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound C1=NC(C(F)(F)F)=CC=C1OC(C(=C1)C#N)=CC=C1COC1=NC(=O)N2CCC3=CC(Cl)=CC=C3C2=C1 RQRDNZUUEJHCPI-UHFFFAOYSA-N 0.000 description 1
• BDOCYPDYZFYQSS-UHFFFAOYSA-N 5-[(9-fluoro-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[5-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound C=1C(F)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 BDOCYPDYZFYQSS-UHFFFAOYSA-N 0.000 description 1
• NGURNKMYCNFKJH-UHFFFAOYSA-N 5-[(9-fluoro-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[6-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound C=1C(F)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 NGURNKMYCNFKJH-UHFFFAOYSA-N 0.000 description 1
• BOYSIRSFHTWGJM-UHFFFAOYSA-N 5-[(9-fluoro-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound C=1C(F)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 BOYSIRSFHTWGJM-UHFFFAOYSA-N 0.000 description 1
• UFWQKNNEGCPUTN-UHFFFAOYSA-N 5-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[5-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 UFWQKNNEGCPUTN-UHFFFAOYSA-N 0.000 description 1
• WDDHHDOUEDOMGA-UHFFFAOYSA-N 5-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[5-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CN=CC(C(F)(F)F)=C1 WDDHHDOUEDOMGA-UHFFFAOYSA-N 0.000 description 1
• GKSYRYSYHVYMSY-UHFFFAOYSA-N 5-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 GKSYRYSYHVYMSY-UHFFFAOYSA-N 0.000 description 1
• XALHGKKNPHMQCI-UHFFFAOYSA-N 5-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-pyridin-3-yloxybenzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=CN=C1 XALHGKKNPHMQCI-UHFFFAOYSA-N 0.000 description 1
• LCSSHBMJKMUGPJ-UHFFFAOYSA-N 5-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-pyrimidin-5-yloxybenzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CN=CN=C1 LCSSHBMJKMUGPJ-UHFFFAOYSA-N 0.000 description 1
• KKQLJORCKURJAU-UHFFFAOYSA-N 5-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)sulfanylmethyl]-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1SCC(C=C1C#N)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 KKQLJORCKURJAU-UHFFFAOYSA-N 0.000 description 1
• ILZQIXGEANUDBN-UHFFFAOYSA-N 5-[(9-methyl-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[2-(trifluoromethyl)pyrimidin-5-yl]oxybenzonitrile Chemical compound C=1C(C)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CN=C(C(F)(F)F)N=C1 ILZQIXGEANUDBN-UHFFFAOYSA-N 0.000 description 1
• VMIAKWIANOEDAJ-UHFFFAOYSA-N 5-[(9-methyl-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound C=1C(C)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 VMIAKWIANOEDAJ-UHFFFAOYSA-N 0.000 description 1
• HFCCKARMXPVHGJ-UHFFFAOYSA-N 5-[(9-methyl-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[5-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound C=1C(C)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 HFCCKARMXPVHGJ-UHFFFAOYSA-N 0.000 description 1
• JPKATYISHXQNBW-UHFFFAOYSA-N 5-[(9-methyl-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound C=1C(C)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 JPKATYISHXQNBW-UHFFFAOYSA-N 0.000 description 1
• VFARUDRREFDIBW-BQYQJAHWSA-N 5-[(e)-2-methoxyethenyl]-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound N#CC1=CC(/C=C/OC)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 VFARUDRREFDIBW-BQYQJAHWSA-N 0.000 description 1
• LFYQHNQUKDKDQN-VOTSOKGWSA-N 5-[(e)-2-methoxyethenyl]-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound N#CC1=CC(/C=C/OC)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 LFYQHNQUKDKDQN-VOTSOKGWSA-N 0.000 description 1
• VFARUDRREFDIBW-FPLPWBNLSA-N 5-[(z)-2-methoxyethenyl]-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound N#CC1=CC(\C=C/OC)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 VFARUDRREFDIBW-FPLPWBNLSA-N 0.000 description 1
• LFYQHNQUKDKDQN-SREVYHEPSA-N 5-[(z)-2-methoxyethenyl]-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound N#CC1=CC(\C=C/OC)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 LFYQHNQUKDKDQN-SREVYHEPSA-N 0.000 description 1
• KUEJUHZCLHOQPL-UHFFFAOYSA-N 5-[2-[(9-fluoro-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxy]ethyl]-2-[5-(trifluoromethyl)pyridin-2-yl]oxybenzonitrile Chemical compound C=1C(F)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(C=C1C#N)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 KUEJUHZCLHOQPL-UHFFFAOYSA-N 0.000 description 1
• UNOVBORSLWJMFD-UHFFFAOYSA-N 5-[2-[(9-fluoro-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxy]ethyl]-2-[6-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound C=1C(F)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(C=C1C#N)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 UNOVBORSLWJMFD-UHFFFAOYSA-N 0.000 description 1
• JRJOMGPDVSQXGT-UHFFFAOYSA-N 5-[2-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxy]ethyl]-2-[2-(trifluoromethyl)pyrimidin-5-yl]oxybenzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(C=C1C#N)=CC=C1OC1=CN=C(C(F)(F)F)N=C1 JRJOMGPDVSQXGT-UHFFFAOYSA-N 0.000 description 1
• ASIMIAMXUQTFAH-UHFFFAOYSA-N 5-[2-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxy]ethyl]-2-[3-(trifluoromethyl)phenoxy]benzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(C=C1C#N)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 ASIMIAMXUQTFAH-UHFFFAOYSA-N 0.000 description 1
• DEJHSXMXXCNHNG-UHFFFAOYSA-N 5-[2-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxy]ethyl]-2-[5-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCCC(C=C1C#N)=CC=C1OC1=CN=CC(C(F)(F)F)=C1 DEJHSXMXXCNHNG-UHFFFAOYSA-N 0.000 description 1
• BSSYYTUCAPMNCO-UHFFFAOYSA-N 5-[2-chloro-4-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]phenoxy]pyridine-3-carbonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1Cl)=CC=C1OC1=CN=CC(C#N)=C1 BSSYYTUCAPMNCO-UHFFFAOYSA-N 0.000 description 1
• VRWXKGHTLHNLTO-UHFFFAOYSA-N 5-[2-cyano-4-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]phenoxy]pyridine-3-carbonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C#N)=CC=C1OC1=CN=CC(C#N)=C1 VRWXKGHTLHNLTO-UHFFFAOYSA-N 0.000 description 1
• OIYRBAPAKRBNKR-UHFFFAOYSA-N 5-[2-cyano-4-[[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)-methylamino]methyl]phenoxy]pyridine-3-carbonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1N(C)CC(C=C1C#N)=CC=C1OC1=CN=CC(C#N)=C1 OIYRBAPAKRBNKR-UHFFFAOYSA-N 0.000 description 1
• LWPNOKNWPIHRMC-UHFFFAOYSA-N 5-[2-fluoro-4-[(9-methoxy-4-oxo-6,7-dihydropyrimido[6,1-a]isoquinolin-2-yl)oxymethyl]phenoxy]pyridine-3-carbonitrile Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CN=CC(C#N)=C1 LWPNOKNWPIHRMC-UHFFFAOYSA-N 0.000 description 1
• KUQNPWOCXSYJGF-UHFFFAOYSA-N 5-[4-(2-methoxyethenyl)phenoxy]pyrimidine Chemical compound C1=CC(C=COC)=CC=C1OC1=CN=CN=C1 KUQNPWOCXSYJGF-UHFFFAOYSA-N 0.000 description 1
• KUQNPWOCXSYJGF-VOTSOKGWSA-N 5-[4-[(e)-2-methoxyethenyl]phenoxy]pyrimidine Chemical compound C1=CC(/C=C/OC)=CC=C1OC1=CN=CN=C1 KUQNPWOCXSYJGF-VOTSOKGWSA-N 0.000 description 1
• XGWUMWHADDASSB-UHFFFAOYSA-N 5-[4-chloro-3-(trifluoromethyl)phenoxy]-2-(hydroxymethyl)benzonitrile Chemical compound C1=C(C#N)C(CO)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 XGWUMWHADDASSB-UHFFFAOYSA-N 0.000 description 1
• YDZVQWCVKXYGIU-UHFFFAOYSA-N 5-amino-2-methylbenzonitrile Chemical compound CC1=CC=C(N)C=C1C#N YDZVQWCVKXYGIU-UHFFFAOYSA-N 0.000 description 1
• GYCPLYCTMDTEPU-UHFFFAOYSA-N 5-bromopyrimidine Chemical compound BrC1=CN=CN=C1 GYCPLYCTMDTEPU-UHFFFAOYSA-N 0.000 description 1
• VPQICCOHFSGBMA-UHFFFAOYSA-N 5-bromopyrimidine-2-carbonitrile Chemical compound BrC1=CN=C(C#N)N=C1 VPQICCOHFSGBMA-UHFFFAOYSA-N 0.000 description 1
• HZVHOILAWGOYKI-UHFFFAOYSA-N 6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C1=CC=C2CCN3C(=O)N=CC=C3C2=C1 HZVHOILAWGOYKI-UHFFFAOYSA-N 0.000 description 1
• DLWFCIUDGCZTLI-UHFFFAOYSA-N 6-[4-chloro-3-(trifluoromethyl)phenoxy]pyridine-3-carbaldehyde Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(OC=2N=CC(C=O)=CC=2)=C1 DLWFCIUDGCZTLI-UHFFFAOYSA-N 0.000 description 1
• PKUFNWPSFCOSLU-UHFFFAOYSA-N 6-chloro-1h-pyrimidine-2,4-dione Chemical compound ClC1=CC(=O)NC(=O)N1 PKUFNWPSFCOSLU-UHFFFAOYSA-N 0.000 description 1
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• PALDCMGKQZFRMF-UHFFFAOYSA-N 9-fluoro-2-[[3-fluoro-4-[2-(trifluoromethyl)pyrimidin-5-yl]oxyphenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(F)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CN=C(C(F)(F)F)N=C1 PALDCMGKQZFRMF-UHFFFAOYSA-N 0.000 description 1
• NNTDFLSDCRXAIG-UHFFFAOYSA-N 9-fluoro-2-[[3-fluoro-4-[4-fluoro-3-(trifluoromethyl)phenoxy]phenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(F)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1F)=CC=C1OC1=CC=C(F)C(C(F)(F)F)=C1 NNTDFLSDCRXAIG-UHFFFAOYSA-N 0.000 description 1
• JHNGPDADNKAMFQ-UHFFFAOYSA-N 9-methoxy-2-[(6-pyridin-4-yloxypyridin-3-yl)methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=N1)=CC=C1OC1=CC=NC=C1 JHNGPDADNKAMFQ-UHFFFAOYSA-N 0.000 description 1
• UUXHOWGCPRYUNY-UHFFFAOYSA-N 9-methoxy-2-[[2-(trifluoromethyl)-4-[3-(trifluoromethyl)phenoxy]phenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C(=C1)C(F)(F)F)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 UUXHOWGCPRYUNY-UHFFFAOYSA-N 0.000 description 1
• ILJMEOVHNRWIDG-UHFFFAOYSA-N 9-methoxy-2-[[3-(trifluoromethyl)-4-[3-(trifluoromethyl)phenoxy]phenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1C(F)(F)F)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 ILJMEOVHNRWIDG-UHFFFAOYSA-N 0.000 description 1
• WSFXNTRHTMKBKD-UHFFFAOYSA-N 9-methoxy-2-[[3-methoxy-4-[3-(trifluoromethyl)phenoxy]phenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1OC)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 WSFXNTRHTMKBKD-UHFFFAOYSA-N 0.000 description 1
• NNYOAPCRCDTNFM-UHFFFAOYSA-N 9-methoxy-2-[[4-(5-methylpyridin-3-yl)oxyphenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1)=CC=C1OC1=CN=CC(C)=C1 NNYOAPCRCDTNFM-UHFFFAOYSA-N 0.000 description 1
• GXJRFGVCZXAGND-UHFFFAOYSA-N 9-methoxy-2-[[4-[3-(trifluoromethyl)phenoxy]phenyl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C=1C(OC)=CC=C2C=1CCN(C(N=1)=O)C2=CC=1OCC(C=C1)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 GXJRFGVCZXAGND-UHFFFAOYSA-N 0.000 description 1
• QLCJWTWVMQBVIV-UHFFFAOYSA-N 9-methoxy-6,7-dihydropyrimido[6,1-a]isoquinoline-2,4-dione Chemical compound C=1C(OC)=CC=C2C=1CCN1C2=CC(O)=NC1=O QLCJWTWVMQBVIV-UHFFFAOYSA-N 0.000 description 1
• 244000215068 Acacia senegal Species 0.000 description 1
• NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
• OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 description 1
• 239000004229 Alkannin Substances 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
• 206010003267 Arthritis reactive Diseases 0.000 description 1
• BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
• XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
• XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 1
• 208000009137 Behcet syndrome Diseases 0.000 description 1
• OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
• 206010057361 Blood brain barrier defect Diseases 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• FFIANHVBVFPUHD-UHFFFAOYSA-N Brc1ccccc1CCOC1OCCCC1 Chemical compound Brc1ccccc1CCOC1OCCCC1 FFIANHVBVFPUHD-UHFFFAOYSA-N 0.000 description 1
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
• FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
• LNPBODQZZISPCB-ULERAKTPSA-N C/C(/C#N)=C\C(\Oc(ccc(C=O)c1)c1Cl)=C/N=C Chemical compound C/C(/C#N)=C\C(\Oc(ccc(C=O)c1)c1Cl)=C/N=C LNPBODQZZISPCB-ULERAKTPSA-N 0.000 description 1
• ZODHPLMTOYEEOM-IOJGMCHMSA-N C/C=C\C=C(/N=[I]/C(F)(F)F)\OC1=CCCC=C1C#N Chemical compound C/C=C\C=C(/N=[I]/C(F)(F)F)\OC1=CCCC=C1C#N ZODHPLMTOYEEOM-IOJGMCHMSA-N 0.000 description 1
• FDZKIRPIFSBZJH-UHFFFAOYSA-N CC(C=C1)=NCC1Oc1ccc(C=O)cc1Cl Chemical compound CC(C=C1)=NCC1Oc1ccc(C=O)cc1Cl FDZKIRPIFSBZJH-UHFFFAOYSA-N 0.000 description 1
• OHNWJFZRTMTWNI-UHFFFAOYSA-N COC1C=CC(C(N2CC3)=CC(OCCc(cc4)cc(F)c4Oc4cccc(C(F)(F)F)n4)=NC2=O)=C3C1 Chemical compound COC1C=CC(C(N2CC3)=CC(OCCc(cc4)cc(F)c4Oc4cccc(C(F)(F)F)n4)=NC2=O)=C3C1 OHNWJFZRTMTWNI-UHFFFAOYSA-N 0.000 description 1
• NIBGNGBQRGQUCF-ZUWFHJRGSA-N COCC/C=C(/C(N1)=CC(OCC2N=CC(Oc(cc3)cc(C(F)(F)F)c3F)=CC2)=N[I]1O)\I Chemical compound COCC/C=C(/C(N1)=CC(OCC2N=CC(Oc(cc3)cc(C(F)(F)F)c3F)=CC2)=N[I]1O)\I NIBGNGBQRGQUCF-ZUWFHJRGSA-N 0.000 description 1
• XVDLAHZHSOIOHS-UHFFFAOYSA-N COc(cc1)cc(CCN23)c1C2=CC(OCc(cc1)cc(F)c1Oc1cnc(C(F)(F)F)nc1)=NC3=O Chemical compound COc(cc1)cc(CCN23)c1C2=CC(OCc(cc1)cc(F)c1Oc1cnc(C(F)(F)F)nc1)=NC3=O XVDLAHZHSOIOHS-UHFFFAOYSA-N 0.000 description 1
• 102000055006 Calcitonin Human genes 0.000 description 1
• 108060001064 Calcitonin Proteins 0.000 description 1
• 229940127291 Calcium channel antagonist Drugs 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 208000002177 Cataract Diseases 0.000 description 1
• LQZQSZYECYSUFV-UHFFFAOYSA-N Cc(cc1)cc(CCN23)c1C2=CC(OCc(cc1F)cc(F)c1Oc1cnc(C(F)(F)F)nc1)=NC3=O Chemical compound Cc(cc1)cc(CCN23)c1C2=CC(OCc(cc1F)cc(F)c1Oc1cnc(C(F)(F)F)nc1)=NC3=O LQZQSZYECYSUFV-UHFFFAOYSA-N 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 208000005145 Cerebral amyloid angiopathy Diseases 0.000 description 1
• 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
• ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
• 229940127328 Cholesterol Synthesis Inhibitors Drugs 0.000 description 1
• 208000016623 Choroid neoplasm Diseases 0.000 description 1
• OZZLCSXOTQGXHQ-UHFFFAOYSA-N ClC1=NCN2C(C3=CC=C(C=C3CC2)OC)=C1 Chemical compound ClC1=NCN2C(C3=CC=C(C=C3CC2)OC)=C1 OZZLCSXOTQGXHQ-UHFFFAOYSA-N 0.000 description 1
• 229940126657 Compound 17 Drugs 0.000 description 1
• 229920002785 Croscarmellose sodium Polymers 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
• 208000000655 Distemper Diseases 0.000 description 1
• 208000001351 Epiretinal Membrane Diseases 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• IYXGSMUGOJNHAZ-UHFFFAOYSA-N Ethyl malonate Chemical compound CCOC(=O)CC(=O)OCC IYXGSMUGOJNHAZ-UHFFFAOYSA-N 0.000 description 1
• PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
• 239000004230 Fast Yellow AB Substances 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
• BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 229920002907 Guar gum Polymers 0.000 description 1
• 229920000084 Gum arabic Polymers 0.000 description 1
• 101000983077 Homo sapiens Phospholipase A2 Proteins 0.000 description 1
• 102000004157 Hydrolases Human genes 0.000 description 1
• 108090000604 Hydrolases Proteins 0.000 description 1
• 208000035150 Hypercholesterolemia Diseases 0.000 description 1
• 239000004233 Indanthrene blue RS Substances 0.000 description 1
• 206010061216 Infarction Diseases 0.000 description 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
• 241000764238 Isis Species 0.000 description 1
• 208000003456 Juvenile Arthritis Diseases 0.000 description 1
• 206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 1
• 208000011200 Kawasaki disease Diseases 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 229910010082 LiAlH Inorganic materials 0.000 description 1
• 108010033266 Lipoprotein(a) Proteins 0.000 description 1
• 102000057248 Lipoprotein(a) Human genes 0.000 description 1
• 208000016604 Lyme disease Diseases 0.000 description 1
• 208000031471 Macular fibrosis Diseases 0.000 description 1
• PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 238000006845 Michael addition reaction Methods 0.000 description 1
• PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 1
• OSDJAOKVLDUAAV-UHFFFAOYSA-N N#Cc(cc(COC(C=C1N2CCc3c1cccc3)=NC2=O)cc1)c1Oc1cnc(C(F)(F)F)nc1 Chemical compound N#Cc(cc(COC(C=C1N2CCc3c1cccc3)=NC2=O)cc1)c1Oc1cnc(C(F)(F)F)nc1 OSDJAOKVLDUAAV-UHFFFAOYSA-N 0.000 description 1
• ZKGNPQKYVKXMGJ-UHFFFAOYSA-N N,N-dimethylacetamide Chemical compound CN(C)C(C)=O.CN(C)C(C)=O ZKGNPQKYVKXMGJ-UHFFFAOYSA-N 0.000 description 1
• 229910002651 NO3 Inorganic materials 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
• 239000005642 Oleic acid Substances 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• 208000003435 Optic Neuritis Diseases 0.000 description 1
• 239000004235 Orange GGN Substances 0.000 description 1
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
• 102000000536 PPAR gamma Human genes 0.000 description 1
• 108010016731 PPAR gamma Proteins 0.000 description 1
• 229910002666 PdCl2 Inorganic materials 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 241000009328 Perro Species 0.000 description 1
• ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
• 239000004237 Ponceau 6R Substances 0.000 description 1
• 239000004236 Ponceau SX Substances 0.000 description 1
• TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
• 201000004681 Psoriasis Diseases 0.000 description 1
• 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
• 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
• LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
• 206010063837 Reperfusion injury Diseases 0.000 description 1
• 206010038848 Retinal detachment Diseases 0.000 description 1
• 206010038899 Retinal telangiectasia Diseases 0.000 description 1
• 206010038910 Retinitis Diseases 0.000 description 1
• 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
• 239000004231 Riboflavin-5-Sodium Phosphate Substances 0.000 description 1
• IIDJRNMFWXDHID-UHFFFAOYSA-N Risedronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CC1=CC=CN=C1 IIDJRNMFWXDHID-UHFFFAOYSA-N 0.000 description 1
• 206010040047 Sepsis Diseases 0.000 description 1
• 229910004298 SiO 2 Inorganic materials 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• STSCVKRWJPWALQ-UHFFFAOYSA-N TRIFLUOROACETIC ACID ETHYL ESTER Chemical compound CCOC(=O)C(F)(F)F STSCVKRWJPWALQ-UHFFFAOYSA-N 0.000 description 1
• 229920002253 Tannate Polymers 0.000 description 1
• 108010049264 Teriparatide Proteins 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 208000001445 Uveomeningoencephalitic Syndrome Diseases 0.000 description 1
• 206010063661 Vascular encephalopathy Diseases 0.000 description 1
• 208000035868 Vascular inflammations Diseases 0.000 description 1
• 208000034705 Vogt-Koyanagi-Harada syndrome Diseases 0.000 description 1
• 238000007239 Wittig reaction Methods 0.000 description 1
• 239000004234 Yellow 2G Substances 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
• KLVZYNDKOYXHPO-UHFFFAOYSA-N [2-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)-2-hydroxyethyl] acetate Chemical compound CC(=O)OCC(O)=C1C(=O)OC(C)(C)OC1=O KLVZYNDKOYXHPO-UHFFFAOYSA-N 0.000 description 1
• SANXNTSSFWATDV-UHFFFAOYSA-N [3,5-difluoro-4-[3-(trifluoromethyl)phenoxy]phenyl]methanamine Chemical compound FC1=CC(CN)=CC(F)=C1OC1=CC=CC(C(F)(F)F)=C1 SANXNTSSFWATDV-UHFFFAOYSA-N 0.000 description 1
• CXYCUOFBSAVOMO-UHFFFAOYSA-N [3-(trifluoromethyl)-4-[3-(trifluoromethyl)phenoxy]phenyl]methanol Chemical compound FC(F)(F)C1=CC(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 CXYCUOFBSAVOMO-UHFFFAOYSA-N 0.000 description 1
• WOAORAPRPVIATR-UHFFFAOYSA-N [3-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC(C(F)(F)F)=C1 WOAORAPRPVIATR-UHFFFAOYSA-N 0.000 description 1
• ONFBSEBTIUDNGZ-UHFFFAOYSA-N [3-chloro-4-[6-(trifluoromethyl)pyridin-3-yl]oxyphenyl]methanol Chemical compound ClC1=CC(CO)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 ONFBSEBTIUDNGZ-UHFFFAOYSA-N 0.000 description 1
• CCXVCOUSIHENMU-UHFFFAOYSA-N [3-fluoro-4-[3-(trifluoromethyl)phenoxy]phenyl]methanamine Chemical compound FC1=CC(CN)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 CCXVCOUSIHENMU-UHFFFAOYSA-N 0.000 description 1
• ZEYBOFWTOYUWOJ-UHFFFAOYSA-N [3-fluoro-4-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methanol Chemical compound FC1=CC(CO)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 ZEYBOFWTOYUWOJ-UHFFFAOYSA-N 0.000 description 1
• NJGJSVAVILSURP-UHFFFAOYSA-N [4-(4-methylimidazol-1-yl)phenyl]methanol Chemical compound C1=NC(C)=CN1C1=CC=C(CO)C=C1 NJGJSVAVILSURP-UHFFFAOYSA-N 0.000 description 1
• ZHFSXVMAZDCSRX-UHFFFAOYSA-N [4-[2-(trifluoromethyl)pyrimidin-5-yl]oxyphenyl]methanol Chemical compound C1=CC(CO)=CC=C1OC1=CN=C(C(F)(F)F)N=C1 ZHFSXVMAZDCSRX-UHFFFAOYSA-N 0.000 description 1
• TVFNRXXCKXXGGU-UHFFFAOYSA-N [4-[3-(trifluoromethyl)phenoxy]phenyl]methanol Chemical compound C1=CC(CO)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 TVFNRXXCKXXGGU-UHFFFAOYSA-N 0.000 description 1
• UQEVLCBMRCKHMM-UHFFFAOYSA-N [4-[4-chloro-3-(trifluoromethyl)phenoxy]phenyl]methanamine Chemical compound C1=CC(CN)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 UQEVLCBMRCKHMM-UHFFFAOYSA-N 0.000 description 1
• UOGCMIDHVWTYEZ-UHFFFAOYSA-N [4-[4-chloro-3-(trifluoromethyl)phenoxy]phenyl]methanol Chemical compound C1=CC(CO)=CC=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 UOGCMIDHVWTYEZ-UHFFFAOYSA-N 0.000 description 1
• BDKZHNJTLHOSDW-UHFFFAOYSA-N [Na].CC(O)=O Chemical compound [Na].CC(O)=O BDKZHNJTLHOSDW-UHFFFAOYSA-N 0.000 description 1
• 235000010489 acacia gum Nutrition 0.000 description 1
• 239000000205 acacia gum Substances 0.000 description 1
• VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
• IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
• KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
• 239000012346 acetyl chloride Substances 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 229940048053 acrylate Drugs 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 230000006022 acute inflammation Effects 0.000 description 1
• 208000038016 acute inflammation Diseases 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 229940062527 alendronate Drugs 0.000 description 1
• 235000019232 alkannin Nutrition 0.000 description 1
• 150000003973 alkyl amines Chemical class 0.000 description 1
• 239000004191 allura red AC Substances 0.000 description 1
• 235000012741 allura red AC Nutrition 0.000 description 1
• 239000004178 amaranth Substances 0.000 description 1
• 235000012735 amaranth Nutrition 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• 208000007502 anemia Diseases 0.000 description 1
• 210000002551 anterior cerebral artery Anatomy 0.000 description 1
• 239000004004 anti-anginal agent Substances 0.000 description 1
• 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
• 229940121363 anti-inflammatory agent Drugs 0.000 description 1
• 239000002260 anti-inflammatory agent Substances 0.000 description 1
• 229940124345 antianginal agent Drugs 0.000 description 1
• 239000003529 anticholesteremic agent Substances 0.000 description 1
• 229940127226 anticholesterol agent Drugs 0.000 description 1
• 239000002220 antihypertensive agent Substances 0.000 description 1
• 229940030600 antihypertensive agent Drugs 0.000 description 1
• 239000003524 antilipemic agent Substances 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 235000006708 antioxidants Nutrition 0.000 description 1
• 229940039856 aricept Drugs 0.000 description 1
• 150000004982 aromatic amines Chemical class 0.000 description 1
• 229940072107 ascorbate Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 239000000305 astragalus gummifer gum Substances 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• 238000011914 asymmetric synthesis Methods 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• 229960005370 atorvastatin Drugs 0.000 description 1
• 239000004176 azorubin Substances 0.000 description 1
• 235000012733 azorubine Nutrition 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 229940077388 benzenesulfonate Drugs 0.000 description 1
• VZFLMGRPVHYDGH-UHFFFAOYSA-N benzenesulfonic acid 2-hydroxyethanesulfonic acid Chemical compound OCCS(O)(=O)=O.OS(=O)(=O)c1ccccc1 VZFLMGRPVHYDGH-UHFFFAOYSA-N 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• 238000004166 bioassay Methods 0.000 description 1
• 238000010256 biochemical assay Methods 0.000 description 1
• 125000005340 bisphosphate group Chemical group 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 230000037118 bone strength Effects 0.000 description 1
• 229910000085 borane Inorganic materials 0.000 description 1
• 239000004161 brilliant blue FCF Substances 0.000 description 1
• 235000012745 brilliant blue FCF Nutrition 0.000 description 1
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
• 125000005998 bromoethyl group Chemical group 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 229910000024 caesium carbonate Inorganic materials 0.000 description 1
• 230000002308 calcification Effects 0.000 description 1
• BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
• 229960004015 calcitonin Drugs 0.000 description 1
• FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
• CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
• 239000008116 calcium stearate Substances 0.000 description 1
• 235000013539 calcium stearate Nutrition 0.000 description 1
• 239000007894 caplet Substances 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
• 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
• 239000004106 carminic acid Substances 0.000 description 1
• 235000012730 carminic acid Nutrition 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 210000004027 cell Anatomy 0.000 description 1
• 208000015114 central nervous system disease Diseases 0.000 description 1
• 201000005667 central retinal vein occlusion Diseases 0.000 description 1
• 229960005110 cerivastatin Drugs 0.000 description 1
• SEERZIQQUAZTOL-ANMDKAQQSA-N cerivastatin Chemical compound COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 SEERZIQQUAZTOL-ANMDKAQQSA-N 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• KVSASDOGYIBWTA-UHFFFAOYSA-N chloro benzoate Chemical compound ClOC(=O)C1=CC=CC=C1 KVSASDOGYIBWTA-UHFFFAOYSA-N 0.000 description 1
• 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
• 201000004709 chorioretinitis Diseases 0.000 description 1
• 201000002588 choroid cancer Diseases 0.000 description 1
• 208000019069 chronic childhood arthritis Diseases 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 208000037976 chronic inflammation Diseases 0.000 description 1
• 230000006020 chronic inflammation Effects 0.000 description 1
• 230000001886 ciliary effect Effects 0.000 description 1
• 229940001468 citrate Drugs 0.000 description 1
• 239000001679 citrus red 2 Substances 0.000 description 1
• 235000013986 citrus red 2 Nutrition 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 208000010877 cognitive disease Diseases 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 229940126142 compound 16 Drugs 0.000 description 1
• 229940125898 compound 5 Drugs 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 235000008504 concentrate Nutrition 0.000 description 1
• 208000026758 coronary atherosclerosis Diseases 0.000 description 1
• 239000006184 cosolvent Substances 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 229960005168 croscarmellose Drugs 0.000 description 1
• 229960000913 crospovidone Drugs 0.000 description 1
• 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
• 239000004148 curcumin Substances 0.000 description 1
• 125000000392 cycloalkenyl group Chemical group 0.000 description 1
• DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 238000010511 deprotection reaction Methods 0.000 description 1
• 239000002274 desiccant Substances 0.000 description 1
• 229910052805 deuterium Inorganic materials 0.000 description 1
• 125000004431 deuterium atom Chemical group 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 235000019700 dicalcium phosphate Nutrition 0.000 description 1
• 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
• 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
• IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
• BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 1
• UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
• UZZWBUYVTBPQIV-UHFFFAOYSA-N dme dimethoxyethane Chemical compound COCCOC.COCCOC UZZWBUYVTBPQIV-UHFFFAOYSA-N 0.000 description 1
• CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
• POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
• 229960003530 donepezil Drugs 0.000 description 1
• 230000003828 downregulation Effects 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 239000004174 erythrosine Substances 0.000 description 1
• 235000012732 erythrosine Nutrition 0.000 description 1
• AFAXGSQYZLGZPG-UHFFFAOYSA-L ethane-1,2-disulfonate Chemical compound [O-]S(=O)(=O)CCS([O-])(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-L 0.000 description 1
• OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
• WGQSPCCCBKQNEV-UHFFFAOYSA-N ethyl 5,6-dichloropyridine-3-carboxylate Chemical compound CCOC(=O)C1=CN=C(Cl)C(Cl)=C1 WGQSPCCCBKQNEV-UHFFFAOYSA-N 0.000 description 1
• JVBHUPITTSCCKT-UHFFFAOYSA-N ethyl 5-chloro-6-[3-(trifluoromethyl)phenoxy]pyridine-3-carboxylate Chemical compound ClC1=CC(C(=O)OCC)=CN=C1OC1=CC=CC(C(F)(F)F)=C1 JVBHUPITTSCCKT-UHFFFAOYSA-N 0.000 description 1
• 238000001704 evaporation Methods 0.000 description 1
• 230000008020 evaporation Effects 0.000 description 1
• 229940108366 exelon Drugs 0.000 description 1
• ZZCHHVUQYRMYLW-HKBQPEDESA-N farglitazar Chemical compound N([C@@H](CC1=CC=C(C=C1)OCCC=1N=C(OC=1C)C=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1C(=O)C1=CC=CC=C1 ZZCHHVUQYRMYLW-HKBQPEDESA-N 0.000 description 1
• 235000019233 fast yellow AB Nutrition 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• 239000011737 fluorine Substances 0.000 description 1
• 125000001153 fluoro group Chemical group F* 0.000 description 1
• 229960003765 fluvastatin Drugs 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 235000003599 food sweetener Nutrition 0.000 description 1
• 229940050411 fumarate Drugs 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 229960003980 galantamine Drugs 0.000 description 1
• ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 239000003979 granulating agent Substances 0.000 description 1
• 230000005484 gravity Effects 0.000 description 1
• 235000010417 guar gum Nutrition 0.000 description 1
• 239000000665 guar gum Substances 0.000 description 1
• 229960002154 guar gum Drugs 0.000 description 1
• 210000004326 gyrus cinguli Anatomy 0.000 description 1
• 150000002367 halogens Chemical class 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 230000002008 hemorrhagic effect Effects 0.000 description 1
• MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
• IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 239000012456 homogeneous solution Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 239000003906 humectant Substances 0.000 description 1
• 150000002430 hydrocarbons Chemical group 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
• 230000000260 hypercholesteremic effect Effects 0.000 description 1
• 230000006951 hyperphosphorylation Effects 0.000 description 1
• 238000005417 image-selected in vivo spectroscopy Methods 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 235000019239 indanthrene blue RS Nutrition 0.000 description 1
• 239000004179 indigotine Substances 0.000 description 1
• 235000012738 indigotine Nutrition 0.000 description 1
• 230000006882 induction of apoptosis Effects 0.000 description 1
• 230000007574 infarction Effects 0.000 description 1
• 230000004968 inflammatory condition Effects 0.000 description 1
• 208000027866 inflammatory disease Diseases 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 238000012739 integrated shape imaging system Methods 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 229910052740 iodine Inorganic materials 0.000 description 1
• 239000011630 iodine Substances 0.000 description 1
• 125000002346 iodo group Chemical group I* 0.000 description 1
• 230000007794 irritation Effects 0.000 description 1
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
• KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 201000002215 juvenile rheumatoid arthritis Diseases 0.000 description 1
• 229940116871 l-lactate Drugs 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 229940070765 laurate Drugs 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
• 230000008752 local inflammatory process Effects 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 229960004844 lovastatin Drugs 0.000 description 1
• PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
• QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
• 235000019341 magnesium sulphate Nutrition 0.000 description 1
• 206010025482 malaise Diseases 0.000 description 1
• 229940049920 malate Drugs 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 230000000873 masking effect Effects 0.000 description 1
• 238000001819 mass spectrum Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• GXHFUVWIGNLZSC-UHFFFAOYSA-N meldrum's acid Chemical compound CC1(C)OC(=O)CC(=O)O1 GXHFUVWIGNLZSC-UHFFFAOYSA-N 0.000 description 1
• 230000003340 mental effect Effects 0.000 description 1
• OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 1
• XGDZEDRBLVIUMX-UHFFFAOYSA-N methyl 2-(4-hydroxyphenyl)acetate Chemical compound COC(=O)CC1=CC=C(O)C=C1 XGDZEDRBLVIUMX-UHFFFAOYSA-N 0.000 description 1
• IZYBEMGNIUSSAX-UHFFFAOYSA-N methyl benzenecarboperoxoate Chemical compound COOC(=O)C1=CC=CC=C1 IZYBEMGNIUSSAX-UHFFFAOYSA-N 0.000 description 1
• 229940095102 methyl benzoate Drugs 0.000 description 1
• LRMHVVPPGGOAJQ-UHFFFAOYSA-N methyl nitrate Chemical compound CO[N+]([O-])=O LRMHVVPPGGOAJQ-UHFFFAOYSA-N 0.000 description 1
• VKTOBGBZBCELGC-UHFFFAOYSA-M methyl(triphenoxy)phosphanium;iodide Chemical compound [I-].C=1C=CC=CC=1O[P+](OC=1C=CC=CC=1)(C)OC1=CC=CC=C1 VKTOBGBZBCELGC-UHFFFAOYSA-M 0.000 description 1
• 210000000274 microglia Anatomy 0.000 description 1
• 208000027061 mild cognitive impairment Diseases 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 239000012046 mixed solvent Substances 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 239000003068 molecular probe Substances 0.000 description 1
• 239000002808 molecular sieve Substances 0.000 description 1
• 125000002950 monocyclic group Chemical group 0.000 description 1
• 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 description 1
• 208000010125 myocardial infarction Diseases 0.000 description 1
• PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
• PEECTLLHENGOKU-UHFFFAOYSA-N n,n-dimethylpyridin-4-amine Chemical compound CN(C)C1=CC=NC=C1.CN(C)C1=CC=NC=C1 PEECTLLHENGOKU-UHFFFAOYSA-N 0.000 description 1
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
• 230000001338 necrotic effect Effects 0.000 description 1
• 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 201000002165 neuroretinitis Diseases 0.000 description 1
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
• 125000004433 nitrogen atom Chemical group N* 0.000 description 1
• VWBWQOUWDOULQN-UHFFFAOYSA-N nmp n-methylpyrrolidone Chemical compound CN1CCCC1=O.CN1CCCC1=O VWBWQOUWDOULQN-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
• 239000006186 oral dosage form Substances 0.000 description 1
• 235000019236 orange GGN Nutrition 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 239000012074 organic phase Substances 0.000 description 1
• 208000005368 osteomalacia Diseases 0.000 description 1
• 108010071584 oxidized low density lipoprotein Proteins 0.000 description 1
• 229910052763 palladium Inorganic materials 0.000 description 1
• PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 210000001152 parietal lobe Anatomy 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 239000006072 paste Substances 0.000 description 1
• 239000004177 patent blue V Substances 0.000 description 1
• 235000012736 patent blue V Nutrition 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
• 235000020030 perry Nutrition 0.000 description 1
• 229940124531 pharmaceutical excipient Drugs 0.000 description 1
• 229940049953 phenylacetate Drugs 0.000 description 1
• WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
• XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
• XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
• 238000013310 pig model Methods 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 229960005095 pioglitazone Drugs 0.000 description 1
• 230000007505 plaque formation Effects 0.000 description 1
• 239000004014 plasticizer Substances 0.000 description 1
• 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
• 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 239000004175 ponceau 4R Substances 0.000 description 1
• 235000012731 ponceau 4R Nutrition 0.000 description 1
• 235000019238 ponceau 6R Nutrition 0.000 description 1
• 235000019237 ponceau SX Nutrition 0.000 description 1
• 230000002980 postoperative effect Effects 0.000 description 1
• 235000011056 potassium acetate Nutrition 0.000 description 1
• VZOPRCCTKLAGPN-ZFJVMAEJSA-L potassium;sodium;(2r,3r)-2,3-dihydroxybutanedioate;tetrahydrate Chemical compound O.O.O.O.[Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VZOPRCCTKLAGPN-ZFJVMAEJSA-L 0.000 description 1
• 229940069328 povidone Drugs 0.000 description 1
• 229960002965 pravastatin Drugs 0.000 description 1
• TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 description 1
• 238000002953 preparative HPLC Methods 0.000 description 1
• 238000012746 preparative thin layer chromatography Methods 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 150000003141 primary amines Chemical class 0.000 description 1
• FYPMFJGVHOHGLL-UHFFFAOYSA-N probucol Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1SC(C)(C)SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 FYPMFJGVHOHGLL-UHFFFAOYSA-N 0.000 description 1
• 229960003912 probucol Drugs 0.000 description 1
• 230000000770 proinflammatory effect Effects 0.000 description 1
• 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 230000004952 protein activity Effects 0.000 description 1
• 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
• 125000003226 pyrazolyl group Chemical group 0.000 description 1
• 125000000168 pyrrolyl group Chemical group 0.000 description 1
• 239000004172 quinoline yellow Substances 0.000 description 1
• 235000012752 quinoline yellow Nutrition 0.000 description 1
• GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 description 1
• 229960004622 raloxifene Drugs 0.000 description 1
• 208000002574 reactive arthritis Diseases 0.000 description 1
• 239000003642 reactive oxygen metabolite Substances 0.000 description 1
• 239000004180 red 2G Substances 0.000 description 1
• 235000012739 red 2G Nutrition 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 210000001525 retina Anatomy 0.000 description 1
• 230000004264 retinal detachment Effects 0.000 description 1
• 230000002207 retinal effect Effects 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 239000002151 riboflavin Substances 0.000 description 1
• 235000019192 riboflavin Nutrition 0.000 description 1
• 235000019234 riboflavin-5-sodium phosphate Nutrition 0.000 description 1
• 238000007363 ring formation reaction Methods 0.000 description 1
• 229940089617 risedronate Drugs 0.000 description 1
• 229960004136 rivastigmine Drugs 0.000 description 1
• 229960004586 rosiglitazone Drugs 0.000 description 1
• 229960000672 rosuvastatin Drugs 0.000 description 1
• BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 description 1
• 229960001860 salicylate Drugs 0.000 description 1
• 201000000306 sarcoidosis Diseases 0.000 description 1
• 229930195734 saturated hydrocarbon Natural products 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 150000003335 secondary amines Chemical class 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 230000001568 sexual effect Effects 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 235000010413 sodium alginate Nutrition 0.000 description 1
• 239000000661 sodium alginate Substances 0.000 description 1
• 229940005550 sodium alginate Drugs 0.000 description 1
• URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
• 235000017550 sodium carbonate Nutrition 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
• 239000008109 sodium starch glycolate Substances 0.000 description 1
• 229920003109 sodium starch glycolate Polymers 0.000 description 1
• 229940079832 sodium starch glycolate Drugs 0.000 description 1
• GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical class [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 235000010356 sorbitol Nutrition 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 230000000707 stereoselective effect Effects 0.000 description 1
• 239000008174 sterile solution Substances 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical compound NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 description 1
• 239000004173 sunset yellow FCF Substances 0.000 description 1
• 235000012751 sunset yellow FCF Nutrition 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• 229940095064 tartrate Drugs 0.000 description 1
• 239000004149 tartrazine Substances 0.000 description 1
• 235000012756 tartrazine Nutrition 0.000 description 1
• 210000002435 tendon Anatomy 0.000 description 1
• OGBMKVWORPGQRR-UMXFMPSGSA-N teriparatide Chemical compound C([C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CNC=N1 OGBMKVWORPGQRR-UMXFMPSGSA-N 0.000 description 1
• 229960005460 teriparatide Drugs 0.000 description 1
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 150000003512 tertiary amines Chemical class 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
• CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
• WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
• 210000001103 thalamus Anatomy 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 238000004809 thin layer chromatography Methods 0.000 description 1
• 150000007970 thio esters Chemical class 0.000 description 1
• 125000003396 thiol group Chemical group [H]S* 0.000 description 1
• 210000001578 tight junction Anatomy 0.000 description 1
• 230000000451 tissue damage Effects 0.000 description 1
• 231100000827 tissue damage Toxicity 0.000 description 1
• 238000011200 topical administration Methods 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 229960001641 troglitazone Drugs 0.000 description 1
• GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 description 1
• GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 description 1
• WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
• 229910052721 tungsten Inorganic materials 0.000 description 1
• 239000010937 tungsten Substances 0.000 description 1
• 229960005486 vaccine Drugs 0.000 description 1
• 229940070710 valerate Drugs 0.000 description 1
• NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
• 230000006492 vascular dysfunction Effects 0.000 description 1
• 231100000216 vascular lesion Toxicity 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 235000019235 yellow 2G Nutrition 0.000 description 1
• 150000003751 zinc Chemical class 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1